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ABSTRACT
Much evidence indicates that in vertebrates the methylation of DNA at
cytosine residues correlates with gene inactivity. A single methyltransferase
activity, DNA (cytosine-5)-methyltransferase, has been purified from
mammalian cells and its gene (Dnmt) cloned. The crucial importance of
DNA methylation in development was demonstrated by the targeted
mutation of Dnmt in murine embryonic stem (ES) cells (Li et al., 1992).
Embryos with homozygous disruptions of Dnmt die in mid-gestation. In
contrast, homozygous mutant ES cells proliferate normally with their DNA
highly demethylated, though they die upon differentiation.
The research presented in this thesis focused on expressing the Dnmt
cDNA in the background of Dnmt mutant ES cells. Initial attempts using a
cDNA reported by Bestor et al. (1988) and a corresponding promoter region
reported by Rouleau et al. (1992) were unsuccessful in effecting adequate
levels of functional MTase expression. A complete cDNA sequence was
obtained through the cloning of two new 5'-proximal exons, which extend
the open reading frame up to 171 codons upstream of the previously defined
start site. This showed the previously-reported promoter sequence to lie in
the second intron of the gene, with no evidence that it functions in ES cells.
It was found that the extra coding sequence was necessary for functional
expression of the gene in ES cells.
Expression of the wild type Dnmt cDNA in mutant ES cells caused an
increase in methylation of bulk DNA to normal levels, but did not restore the
methylation of imprinted genes, whose expression is monoallelic and
dependent upon their parental derivation. The expression of these genes was
deregulated because of this hypomethylation, as shown previously in Dnmt
mutant embryos (Li et al., 1993). Full restoration of monoallelic methylation
and expression was imposed on imprinted genes upon germline
transmission. These results are consistent with the presence of distinct de
novo DNA methyltransferase activities during oogenesis and
spermatogenesis which specifically recognize imprinted genes but which are
absent in the post-implantation embryo and in ES cells.
Because the "rescued" ES cells display biallelic hypomethylation and
expression of imprinted genes, their developmental capacities may be
impaired, as is seen with cells derived from parthenogenetic or androgenetic
embryos, which also display biallelic expression of imprinted genes.
Alternatively, the rescued ES cells may have normal developmental
capacities, as predicted by a model which explains genomic imprinting as a
nonessential, evolutionarily-recent addition to the basic mammalian
developmental program. Rescued cells differentiated normally in vitro,
formed teratomas with a wide variety of differentiated cell types, and
contributed substantially to coat color in adult chimeras. Further analysis of
tissue-specific distribution of rescued ES cells in chimeras will allow a full
assessment of the developmental potential of a mouse lacking an imprinted
genome.
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Super cuncta est murium fetus, haut sine cunctatione dicendus,
quamquam sub auctore Aristotele et Alexandri Magni militibus. generatio
eorum lambendo constare, non coitu, dicitur. ex una genitos cxx tradiderunt,
apud Persas vero praegnantes in ventre parentis repertas; et salis gustatu fieri
praegnantes opinantur. itaque desinit mirum esse unde vis tanta messes
populetur murium agrestium; in quibus illud quoque adhuc latet quonam
modo illa multitudo repente occidat: nam nec exanimes reperiuntur neque
extat qui murem hieme in agro effoderit. plurimi ita ad Troada proveniunt,
et iam inde fugaverunt incolas. proventus eorum siccitatibus. tradunt etiam
obituris vermiculum in capite gigni. Aegyptiis muribus durus pilus sicut
irenaceis; idem bipedes ambulant ceu Alpini quoque.
Plinii, Naturalis Historia, Liber X
"The most prolific of all animals whatever is the mouse - one hesitates
to state its fertility, even though on the authority of Aristotle and the troops
of Alexander the Great. It is stated that impregnation takes place by licking
and not by coupling. There is a record of 120 being born from a single mother,
and in Persia of mice already pregnant being found in the parent's womb; and
it is believed that they are made pregnant by tasting salt. Accordingly it ceases
to be surprising how so large an army of field-mice ravages the crops; and in
the case of field-mice it is also hitherto unknown exactly how this vast
multitude is suddenly destroyed: for they are never found dead, and nobody
exists who ever dug up a mouse in a field in winter. Vast numbers thus
appear in the Troad, and they have by now banished the inhabitants from
that country. They appear during droughts. It is also related that when a
mouse is going to die a worm grows in its head. The mice in Egypt have hard
hair like hedgehogs, and also they walk on two feet, as also do the Alpine
mice."
Translation by H. Rackham
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I. DNA Methylation and DNA Methyltransferases
Cytosine methylation in vertebrate genomes
The genomic DNA of vertebrates, higher plants, and many fungi and
bacteria contains a covalent modification of cytosine, in which a methyl group
is added on to the fifth carbon atom in the pyrimidine ring (for review see Jost
and Saluz, 1993). In vertebrates, this methylation occurs mostly at the
symmetrically opposed cytosines in CpG dinucleotides (Gruenbaum et al.,
1982). This short recognition sequence is underrepresented about five-fold in
the mammalian genome, and about 60% of the 5 x 107 CpG dinucleotides in
the mammalian genome are methylated (Bestor et al., 1984; Gama-Sosa et al.,
1983). Most of the remaining, unmethylated CpG residues are densely
clustered together in CpG islands (Bird, 1986), short regions (averaging 1000 bp
in length) of GC-rich DNA usually found near the promoters of
constitutively-expressed, "housekeeping" genes, which stay hypomethylated
throughout development (Bird, 1986).
A strong inverse correlation has been documented between cytosine
methylation of genes and their transcriptional activity (Yeivin and Razin,
1993). The mechanism by which cytosine methylation inhibits transcriptional
activity is unclear. Some evidence has accumulated that methylation of
specific CpG residues prevents the binding of transcription factors (Comb and
Goodman, 1990; Iguchi-Ariga and Schaffner, 1989; Prendergast et al., 1991; Watt
and Molloy, 1988). However, not all transcription factors are methylation-
sensitive to DNA binding (Hoeller et al., 1988), and few transcription factors
contain the dinucleotide in their recognition sequence. In addition, the new
technique of mapping methylation sites by bisulfite sequencing (Frommer et
al., 1992) has shown that, even within one tissue of a single organism, DNA
methylation patterns at any given gene vary considerably (Feil et al., 1994).
Another possibility is that repression occurs indirectly through recognition of
methylated cytosine residues by nuclear proteins, which can then either
directly block access by the transcriptional apparatus or effect a change in local
chromatin structure disfavoring such access (Boyes and Bird, 1991). Two
proteins have been found which bind specifically to methylated CpG residues
(Lewis et al., 1992; Meehan et al., 1989), and some evidence exists that they can
repress transcription in vitro (Boyes and Bird, 1992; Nan et al., 1997). A similar
mechanism can be envisaged to explain activation of genes when they are
methylated.
There are various explanations of the biological function of
methylation in vertebrates. In prokaryotes methylation-sensitive restriction
endonucleases act as a "host defense mechanism" by digesting foreign,
unmethylated DNA, while methyltransferase activities in turn protect newly-
replicated host DNA by rendering it resistant to the host endonuclease activity
(Noyer-Weidner and Trautner, 1993). This has led to the idea that methylation
protects the vertebrate genome from invasive parasites such as retroviruses
and transposons (Doerfler, 1991), which can damage the functioning of
essential genes by integrating within or nearby them. Indeed, methylation of
retroviral elements results in their transcriptional and transpositional
silencing (Simon et al., 1983; Vardimon et al., 1982), and this unchecked
transposition can cause severe mutations in important genes (Jdhner and
Jaenisch, 1985; Michaud et al., 1994).
Another model proposes that methylation leads to heterochromatic
condensation of "junk" DNA in the large genomes of vertebrates and
angiosperms (Bird, 1995). This compartmentalization allows the
transcriptional apparatus faster access to those genes necessary for cell
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survival, which are characterized by the presence of unmethylated CpG
islands. This theory would explain why organisms with smaller genomes,
such as Drosophila and Saccharomyces, do not possess the methylation
modification system (Proffitt et al., 1984; Urieli-Shoval et al., 1982). However,
the causal relationship between methylation and chromatin structure is
unclear. Little evidence indicates that DNA methylation precedes the
formation of a condensed, transcriptionally inactive chromatin structure
(Buschhausen et al., 1987), and it remains to be seen how closely genome size
correlates with the presence of methylation systems. These two theories are
not mutually exclusive, nor do they exclude the major role that DNA
methylation is thought to play in the control of specific genes during
differentiation and development (Yeivin and Razin, 1993).
Changes in methylation patterns during mammalian development
Methylation patterns change dramatically during murine development.
During gametogenesis, the unmethylated DNA of the primordial germ cells
becomes de novo methylated (Monk et al., 1987), so that specific interspersed
repetitive (Sanford et al., 1987) and single-copy (Kafri et al., 1992) gene
sequences in sperm are hypermethylated relative to the sequences in oocytes.
The methylation present in the DNA of the zygote is erased during cleavage so
that the genome of the blastocyst is almost completely unmethylated (Chaillet
et al., 1991; Kafri et al., 1992; Monk et al., 1987). After implantation, the embryo
undergoes a wave of global de novo methylation which restores the genomic
methylation levels of the gastrulating embryo to levels seen in the adult
(Jihner et al., 1982; Monk et al., 1987), though to a lesser degree in
extraembryonic tissues than in somatic tissues (Chapman et al., 1984; Monk et
al., 1987). The purpose of this erasure and restoration of methylation patterns
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is unclear, but it may be to erase the different methylation patterns inherited
from the male and female gametes and to allow epigenetic differences in the
various gastrulating germ layers to be subsequently established. The only
genes which escape this remethylation are imprinted genes (see below), genes
active during embryogenesis, such as a-fetoprotein (Vedel et al., 1983), and
CpG island-bearing genes (Kafri et al., 1992), which are consistently
unmethylated throughout development. Later in development, different
tissues undergo their own specific demethylation programs which are
implicated in activating genes required in those tissues, though the role
methylation has to play in this is still very unclear.
The Dnmt-encoded MTase has maintenance methylation activity both in vitro
and in vivo
A single methyltransferase activity, the DNA (cytosine-5)-
methyltransferase (MTase, EC 2.1.1.37), has been purified from mammalian
cells (Bestor and Ingram, 1983; Bestor and Ingram, 1985) and its gene cloned
(Bestor et al., 1988). Two lines of evidence have led to the commonly-accepted
view that MTase acts in vivo as a maintenance methyltransferase, which
restores a double-stranded methylation profile to newly-synthesized,
hemimethylated DNA (Fig. 1). Firstly, MTase shows a marked preference for
hemimethylated DNA in vitro (Bestor and Ingram, 1983; Gruenbaum et al.,
1982). Secondly, MTase is shown to co-localize to sites of active DNA
replication in S-phase cells called replication foci (Leonhardt et al., 1992). The
maintenance activity of MTase stands in contrast to de novo
methyltransferase activity, which occurs on completely unmethylated DNA
substrates. Though faithful replication of methylation patterns is probably its
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major role in mammals, it is possible that MTase possesses de novo activity in
vivo.
The enzyme consists of a 1000-amino acid amino-terminal domain with
three peptide motifs (Fig. 2): an amino-terminal nuclear localization signal, a
250-amino acid domain responsible for targeting MTase to replication foci in
the nuclei of dividing cells (Leonhardt et al., 1992), and a zinc-binding zinc-
finger motif (Bestor, 1992). This is followed by a 500 amino acid carboxyl-
terminal domain, assumed to contain the catalytic center from its homology to
cytosine-methylating bacterial type II methyltransferases (Bestor et al., 1988;
Kumar et al., 1994). This domain contains all of the ten consensus motifs
found in this class of enzymes in their invariant order, including the proline-
cysteine amino acid doublet responsible for enzymatic addition to the cytosine
ring (Leonhardt and Bestor, 1993). The two domains of MTase are joined
together by a run of 13 glycyl - lysyl amino acid pairs.
The crystal structure of the bacterial HhaI methyltransferase has recently
been solved (Cheng et al., 1993; Klimasauskas et al., 1994), and the results are
worth mentioning because the highly-conserved protein sequence motifs
shared by MTase and M.HhaI are probably reflective of conservation in
structure and enzymatic function. The crystal structures show M.HhaI to be
organized into two domains, a larger one containing most of the conserved
catalytic motifs, and a smaller one containing residues important for sequence
specificity of the enzyme. The ubiquitous cofactor S-adenosyl-L-methionine
serves as the methyl donor to the C5 residue of the cytosine ring, and the
methyl group is added after a covalent bond has been formed between a
highly-conserved cysteine residue in the enzyme and the C6 residue in the
pyrimidine ring. Amazingly, the crystal structure of the DNA-bound enzyme
shows that the cytosine residue is completely extruded from the B-form DNA
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helix and inserted into the active-site pocket of the enzyme, allowing for the
stereoelectronic attack trajectories, normal to the plane of the cytosine ring,
which are thought necessary for this catalytic mechanism.
The most remarkable functional difference between the bacterial type II
methyltransferases and the mammalian homologues is that the latter
discriminate between hemimethylated and unmethylated DNA substrates
(Bestor and Ingram, 1983). Treatment of purified murine MTase with
protease V8 caused cleavage near the linker separating the catalytic and the
amino-terminal domains, resulting in a large increase in the rate of de novo
methylation without affecting the rate of methylation of hemimethylated
DNA (Bestor, 1992). Unfortunately, the proteolyzed fragments were not
purified, so it is unclear whether MTase possesses de novo activity in the
absence of the amino-terminal domain. It is also unclear by what means the
amino-terminus of MTase could influence the discrimination of
unmethylated versus hemi-methylated substrates, given that steric
considerations probably prevent its direct contact with the major groove
(Bestor, 1992). Proteolytic truncation of the first 350 amino acids does not
affect substrate specificity or in vitro activity (Bestor, 1992; Bestor and Ingram,
1985), so presumably the region of the amino terminus lying C-terminal to
the replication-foci targeting domain is involved in this substrate
discrimination. An elucidation of the atomic structure of MTase bound to its
DNA substrate is eagerly awaited.
Based upon homology to murine and bacterial cytosine
methyltransferases, genes encoding presumptive methyltransferase activities
have been cloned from human (Yen et al., 1992), chicken (Tajima et al., 1995),
sea urchin (Aniello et al., 1996), Xenopus laevis (Kimura et al., 1996) and
Arabidopsis thaliana (Finnegan and Dennis, 1993). Of these five genes, the
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first four are presumed to encode maintenance methyltransferase activities
because of the similarity of their amino-terminal domains to that of the
murine MTase, while the amino-terminal domain from A. thaliana bears no
resemblance to the murine gene and may encode a de novo activity. Weak
evidence also exists for a DNA methyltransferase gene in Drosophila
(Vanyushin and Poirier, 1996). Interestingly, a gene (pmtl + ) bearing
significant homology to both the bacterial and mammalian cytosine
methyltransferases has been cloned from the fission yeast
Schizosaccharomyces pombe, despite the apparent lack of DNA methylation
in this organism (Wilkinson et al., 1995). The enzyme encoded by this gene
possesses no in vitro methylation activity. However, deletion of a serine
residue found in pmtl+ between the canonical proline-cysteine doublet in the
catalytic domain allows for production of an enzyme bearing in vitro and in
vivo methyltransferase activity with the same recognition sequence as both
the E. coli dcm gene product and M.EcoRII (Pinarbasi et al., 1996).
Transcriptional and translational control of Dnmt expression
The transcriptional control of Dnmt is complex. The steady-state level
of Dnmt mRNA increases as synchronized Balb/c 3T3 cells enter S phase of
the cell cycle (Szyf et al., 1991), resulting in a concomitant increase of MTase
that closely matches the synthesis of DNA (Szyf et al., 1985). Despite this
increase in mRNA levels, nuclear run-on assays indicated that Dnmt was
transcribed in resting-cell nuclei at the same rate as in S-phase nuclei,
indicating that the major determinant of mRNA abundance is post-
transcriptional (Szyf et al., 1991). Post-transcriptional down-regulation of
Dnmt gene activity has also been implicated in the differentiation of both F9
mouse embryonal carcinoma cells (Teubner and Schulz, 1995) and myoblasts
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(Liu et al., 1996), where actinomycin-treated nuclei were used to indicate an
increase in Dnmt mRNA turnover.
A putative promoter has been reported for Dnmt (Rouleau et al., 1992).
The authors presented data mapping transcriptional start sites of the gene in
various cell lines using RNase protection and primer extension assays, and
they also employed standard CAT assays in transient transfections to establish
a minimal promoter sequence. As described in Chapter One, this putative
promoter sequence was found incapable of supporting expression of the Dnmt
cDNA in embryonic stem (ES) cells, and no evidence was found for
transcriptional start sites in the places reported by Rouleau et al. Instead, a
region 12 kb upstream of this putative promoter has been found to drive
appropriate expression of Dnmt in ES cells, and is believed to contain the
actual promoter (Tucker et al., 1996b).
The 5.2-kb Dnmt transcript is found in all tissues of the mouse, and at
high levels in ovary, testis, cerebellum, spleen, and heart (Trasler et al., 1992).
These relative differences are reflected in protein levels (D. Talbot,
unpublished observation). Intriguingly, Dnmt was found to be expressed at
low levels in postmitotic neurons in the cerebral cortex, the cerebellar
granular layer, and hippocampal neuronal layers (Goto et al., 1994), while
another report has shown high levels of methyltransferase activity in extracts
made from cerebellum (Brooks et al., 1996). In testis, an additional 6.2-kb
transcript was found. The gradual appearance of this transcript during
spermatocyte maturation correlated with the disappearance of MTase protein,
to the point that the enzyme was undetectable in post-replicative pachytene
spermatocytes, which expressed only the 6.2-kb message (Jue et al., 1995;
Trasler et al., 1992). The significance of this is not at all understood.
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In addition to transcriptional control of Dnmt gene expression, post-
translational control of MTase levels has been observed. In differentiating
myoblasts, levels of MTase decreased more rapidly than markers for cellular
proliferation (Liu et al., 1996), which is accounted for by an increased turnover
rate of MTase, as indicated by pulse-chase experiments.
Subcellular localization of MTase
MTase displays a cell cycle-regulated cellular distribution (Leonhardt et
al., 1992; Vogel et al., 1988). As elucidated by Leonhardt et al. (1992), MTase
colocalizes during S phase with the 1-3 gm toroidal "replication foci" that are
known centers of active DNA replication. Dissection of the protein revealed a
250-amino acid domain in the amino terminus of the protein that is both
sufficient and necessary for localization to replication foci. In addition,
immunofluorescent observations of MTase in developing mouse embryos has
revealed a remarkable mobility of the enzyme. Levels of MTase are very high
throughout preimplantation development, though they decline by more than
a factor of 10 from oocytes to blastocysts (Carlson et al., 1992; Howlett and Reik,
1991; Monk et al., 1991). Despite these high levels, MTase is excluded from the
nucleus in one- to four-cell stage embryos, concentrating in small cytoplasmic
granules near the nuclear periphery (Carlson et al., 1992). By the compacted 8-
cell stage, MTase has moved into the nucleus, but it displays a uniform
staining, unlike the replication foci seen in cultured cells. Blastocysts show a
reversal of this trend, with only faint staining of the nuclei of both trophoblast
and inner cell mass cells. In 5.5 days post coitum (dpc) embryos, MTase has
moved back into the nucleus, and stays localized there throughout
postimplantation development (Trasler et al., 1996). These observations are
difficult to reconcile with observations of declining genomic methylation
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levels in the preimplantation embryo (Chaillet et al., 1991; Monk, 1990; Monk
et al., 1987), because concentrations of MTase in the nucleus are at their
highest during a period when the rate of demethylation of genomic DNA is at
a maximum (Monk, 1990).
Dnmt is essential for normal murine development
The crucial importance of DNA methylation in development was
demonstrated by the targeted mutation of the single known mammalian DNA
methyltransferase gene (Dnmt) in ES cells. Three mutant alleles of the Dnmt
gene have been generated (Fig. 2) (Lei et al., 1996; Li et al., 1993; Li et al., 1992).
A partially inactivated allele (Dnmtn ) caused lethality of homozygous mutant
embryos at the 25 somite stage, whereas embryos homozygous for completely
inactivated alleles (Dnmts and Dnmtc) died at the 5 somite stage. Embryos
displayed morphologically normal major organ rudiments and appeared to be
developmentally delayed by one day, but histological examination revealed
widespread cell death and a low mitotic index (Lei et al., 1996; Trasler et al.,
1996). ES cells homozygous for any of the disrupted Dnmt alleles proliferate
normally with their genomic DNA highly demethylated but die upon
induction of differentiation. Importantly, ES cells homozygous for the Dnmt c-
allele gene disruption retain the ability to de novo methylate transduced
retroviral genomes, as seen in wild-type preimplantation embryos, embryonic
carcinoma (EC), and ES cells (Lei et al., 1996; Stewart et al., 1982). Because this
gene disruption destroys the catalytic capacity of MTase by removing the
proline-cysteine motif, this result strongly suggests the expression in ES cells
of an independently-encoded de novo DNA methyltransferase (Lei et al.,
1996). The identification of this activity is actively being pursued.
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Ectopic expression of cytosine methyltransferases in yeast and mammalian
cell lines
Several attempts at transgenic expression of cytosine
methyltransferases have been reported. Bacterial methyltransferases have
been transfected into yeast and mammalian cells under the control of
heterologous promoters. The Bacillus sphaericus R methyltransferase was
expressed in yeast and reported to cause methylation of endogenous genes
(Feher et al., 1983). Expression of the Bacillus subtilis SPR phage cytosine
methyltransferase in yeast resulted in methylation of CCGG sequences in
various genes, which increased when the expression of the examined genes
was induced (Singh and Klar, 1992). The bacterial HhaI methyltransferase,
which methylates the internal C in the sequence GCGC, has been expressed in
NIH 3T3 cells (Wu et al., 1996). High levels of expression led to cell death,
while lower levels of expression led to increased methylation of genomic
HhaI recognition sequences and to increased clonability in soft agar,
indicating a transformed phenotype.
Two reports of transgenic expression of the mammalian MTase have
appeared in the literature (Vertino et al., 1996; Wu et al., 1993).
Overexpression of the murine MTase in NIH 3T3 cells was claimed to cause a
transformed phenotype (Wu et al., 1993). Definitive evidence of
overexpression was not demonstrated, however, and the results are called
into question by the fact that the cDNA used in the experiments was
incomplete (see Chapter One). The same group reported overexpression of
the human MTase in a human fetal lung fibroblast line immortalized with
SV40 (Vertino et al., 1996). In this paper, up to 20-fold levels of MTase
overexpression were convincingly demonstrated by Western blot and by an
increase in in vitro enzyme activity in cellular extracts of the transgenic
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clones. De novo methylation of 5 / 12 CpG island-bearing genes was
demonstrated for three clones expressing >9-fold levels of MTase. Again,
however, the authors were working with a truncated cDNA, as demonstrated
in the paper by a recombinant MTase with an apparent molecular mass
approximately 10 kDa shorter than the endogenous MTase, which migrates in
SDS-PAGE at 190 kDa. Though this recombinant enzyme showed no increase
in de novo activity in vitro, its apparent toxicity in this and my studies (see
Chapter One) demands caution when interpreting results obtained with it.
Ectopic expression of Dnmt in embryonic stem cells
The embryonic stem (ES) cell offers enormous advantages as a cell line
for experimental manipulation of murine gene expression, because of the
high frequency of homologous recombination in gene-targeting experiments
and the cell's subsequent pluripotency in the production of mice bearing a
desired genetic alteration. Primary cell lines derived from mice bearing such
genetic alterations are favorable to individual clones derived from the
transfection of standard immortalized cells, as described above, because
extended culturing of cells leads to many unpredictable epigenetic changes
which can make interpretations problematic (Antequera et al., 1990). In order
to establish a model of ectopic Dnmt expression in the mouse, I have
attempted to express the Dnmt gene as a transgene in ES cells. Homozygous
mutant Dnmt ES cells are viable and their gross methylation status is easily
ascertained by Southern blot analysis, making amenable the functional
analysis of Dnmt expression in this genetic background.
In contrast to previous published reports (Vertino et al., 1996; Wu et al.,
1993), I was unable to establish stable transfectants when a Dnmt cDNA
sequence was placed under the control of two heterologous promoters,
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murine Pgk-1 and human EF-lc. Subsequent analysis of the 5' end of the
Dnmt mRNA produced in ES cell lines revealed the existence of two new
exons, upstream of the published 5' cDNA sequence terminus (Bestor et al.,
1988), which extend the open reading frame up to 171 codons upstream of the
previously defined start site and show the previously-reported promoter
sequence (Rouleau et al., 1992) to lie in the second intron of the gene, with no
evidence that it functions in ES cells. It was found that the extra coding
sequence was necessary for functional expression of the gene in ES cells.
Expression of the full-length Dnmt cDNA in mutant ES cells was
achieved through a mini-gene construct employing the endogenous Dnmt
promoter (Tucker et al., 1996b). Only when this sequence was restored could
the Dnmt gene product rescue the hypomethylation phenotype of Dnmt
mutant cells. Restoration of normal methylation levels in Dnmt mutant
cells restored their developmental potential; in contrast to the parental
mutant ES cells, the rescued cells were capable of differentiating in vitro and
generating teratomas with a wide variety of differentiated cell types. This
suggests that genomic remethylation resulted in the restoration of the proper
transcriptional program required for differentiation of the ES cells into
different tissues. These data also suggest the existence of an amino-terminal
region of the protein necessary for normal function in vivo.
II. DNA Methylation and Genomic Imprinting
Parthenogenotes and androgenotes are developmentally compromised
For many years it had been known that parthenogenotes, the products
of accidental activation of the unfertilized oocyte, were inviable, but the
reasons for this were unclear (Graham, 1974). The first suggestion that the
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maternal and paternal genomes may be non-equivalent was provided by the
observation that in the extraembryonic tissues of the mouse the paternally-
derived X-chromosome is preferentially inactivated (Takagi and Sasaki, 1975).
The non-equivalence of the maternal and paternal genomes was conclusively
demonstrated by the experimental manipulation of fertilized mouse eggs.
Single maternally- or paternally-derived pronuclei were surgically removed
from one-cell stage embryos and transplanted to recipient embryos, which
themselves lacked either a paternally- or maternally-derived pronucleus,
respectively (McGrath and Solter, 1983). In this fashion biparental diploid
gynogenetic (two maternally-derived pronuclei), androgenetic (two
paternally-derived pronuclei), and normal embryos could be tested for their
ability to develop in utero. Despite the normal developmental potential of
parentally "balanced" control embryos, gynogenotes and androgenotes did not
develop to term, exhibiting complementary deficiencies in developmental
potential (Barton et al., 1984; Mann and Lovell-Badge, 1984; McGrath and
Solter, 1984; Surani et al., 1984). Parthenogenotes/Gynogenotes were found to
develop poorly, becoming arrested at key steps in peri-implantation
development (Sturm et al., 1994; Varmuza et al., 1993). With only about 20%
of embryos surviving to the 10-20-somite stage, the most advanced embryos
appeared morphologically normal but smaller and with very poor
development of extraembryonic membranes and trophoblast (Sturm et al.,
1994; Surani and Barton, 1983; Surani et al., 1984). In contrast, the
preimplantation development of androgenotes was severely compromised
(Barton et al., 1984). Very few embryos progressed to the somite stage, and
none made more than 6-8 somites. However, androgenotes exhibited
extensive proliferation of the extraembryonic tissue. These data clearly
showed that the paternal and maternal genomes are functionally different,
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and that the embryo needs one maternally- and one paternally-derived
haploid genome for normal development to occur. The complementary
phenotypes of parthenogenotes and androgenotes was puzzling, and was
noticed later in analysis of chimeras made with embryonic cells derived from
parthenogenotes or androgenotes (see Conclusion).
Imprinted chromosomal regions in the mouse and human
Ascertaining the importance of genomic imprinting to mammalian
development was hampered by the early-embryonic lethality of androgenetic-
and gynogenetic-embryos. These data have been supplemented by examining
the effects of regional uniparental disomy (UPD) on development of mice and
humans. A series of mice bearing UPD were produced, in which both
homologous copies of a specific chromosome (or portion thereof) were
inherited exclusively from the mother or the father (Cattanach and Kirk,
1985). In this manner, eight autosomal regions were identified which
resulted in developmental and behavioral abnormalities when exhibiting
UPD (Beechey and Cattanach, 1996). The "genetic imprinting map" thus
constructed also suggested that these genomic regions, and presumably
specific genes within them, were responsible for the more severe
developmental abnormalities seen in parthenogenotes and androgenotes.
Analyses in mice have been complemented by the intensive study of
several diseases associated with UPD in the human (reviewed in Lalande,
1996). Developmental abnormalities are caused by the uniparental
inheritance of four regions of the human genome. Prader-Willi syndrome,
which is characterized by hypotonia and slow growth in infancy, mild mental
retardation, and obesity, is caused either by paternally-inherited deletions
(Butler and Palmer, 1983) or maternal UPD (Nicholls et al., 1989) of
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chromosome 15q11-q13. Paternal UPD (Malcolm et al., 1991) or maternally-
inherited deletions (Knoll et al., 1989) of the identical chromosomal region
result in Angelman syndrome, which is characterized by craniofacial
peculiarities, an ataxic gait and jerky arm movements, severe mental
retardation, hyperactivity, seizures, and EEG abnormalities. Maternal UPD of
the syntenic genomic region in mouse (central chromosome 7) was shown to
result in neonatal lethality (Cattanach et al., 1992). Beckwith-Wiedemann
Syndrome (BWS) is associated with multiorgan hyperplasia and a
predisposition to embryonal tumors (Junien, 1992). Both paternal UPD and
paternal duplication of the chromosomal region 11p15.5 results in BWS
(Henry et al., 1991). All BWS-causing paternal duplications and disomies
include the linked genes H19 and Igf2, which are discussed at length in this
thesis. Finally, many other diseases show parent-of-origin effects, such as
Wilms' tumor, rhabdomyosarcoma, neuroblastoma, and Philadelphia-
chromosome-positive leukemia (Reeve, 1995). These results confirm the
observations made in mice, that several discrete regions of the genome cause
phenotypic abnormalities when inherited in a uniparental fashion.
In summary, many lines of evidence have shown that normal
development of both mice and humans requires a balanced contribution of
homologous chromosomes from both parents. Inbred mouse strains have
been used to show that epigenetic differences exist between the haploid
genome donated to the embryo by the father and by the mother. Unbalanced
contribution of maternally- and paternally-derived genomic material to mice
and humans leads to phenotypes ranging from early embryonic lethality, as
seen in murine androgenotes, to milder defects such as the distinguishing
facial characteristics of children with Angelman syndrome. Many phenotypes
were reciprocal (e.g. the ability of parthenogenotes and androgenotes to form
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embryonic and extraembryonic structures, respectively), suggesting the
absence of specific gene products in parthenogenotes which were present in
androgenotes, and vice versa. Differences in expression patterns between the
two cell types may reflect allele-specific differences in transcription levels,
which are determined solely by the parental origin of each allele of a given
"imprinted" gene. The specific location of these imprinted genes was
suggested by the maps of imprinted chromosomal regions developed for the
mouse and by the association of genomic deletions with the human diseases
discussed above. The past five years have seen a flurry of reports describing
the identification of these imprinted genes, and evidence has accumulated to
support the hypothesis that it is their deregulated expression which causes the
developmental defects seen in mice and humans with UPD.
Imprinted genes show allele-specific transcription
Imprinted genes display parent-specific monoallelic expression,
although often not at all developmental stages (Szab6 and Mann, 1995a; Szab6
and Mann, 1995b) or in all tissues of the organism (Latham, 1995). Genes
which are predominantly expressed from the maternal allelel include Igf2r
(Barlow et al., 1991), H19 (Bartolomei et al., 1991), Mash2 (Guillemot et al.,
1995), p5 7KIP2 (Hatada and Mukai, 1995), and KVLQT1 (Lee et al., 1997). Genes
expressed from the paternal allele include Igf2 (DeChiara et al., 1991), Snrpn
(Leff et al., 1992), U2afl-rsl (Hatada et al., 1993), Mas (Villar and Pedersen,
1994), PAR1/PAR5 (Sutcliffe et al., 1994), insl/ins2 (Giddings et al., 1994), IPW
(Wevrick et al., 1994), Pegl/Mest (Kaneko-Ishino et al., 1995), ZNF127 (Jong et
al., 1994), Cdc25Mm (Plass et al., 1996) and Peg3 (Kuroiwa et al., 1996). The
1 "Maternal" and "paternal" allele refers to the allele derived from the mother
and father, respectively.
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existence of many other imprinted genes has been inferred from genetic
criteria (Beechey and Cattanach, 1996), and the total number is estimated
between 100 and 200 (Hayashizaki et al., 1994; Solter, 1988).
Imprinted gene expression is deregulated
in parthenogenotes and androgenotes
Several analyses have been made of imprinted gene expression in
uniparental embryos and their derivatives. If interactions between maternal
and paternal alleles of a given imprinted gene are not necessary to establish
normal imprinted expression of that gene in wild-type embryos, then the
expression of this gene in androgenotes and parthenogenotes should correlate
with the respective uniparental derivation of the embryos. For example, the
maternally-expressed H19 should be biallelically expressed in
parthenogenotes and mice with maternal disomy of distal chromosome 7 (the
chromosomal location of H19), while this gene should be transcriptionally
inactive in androgenotes and mice with paternal disomy of distal
chromosome 7. Several laboratories have reported analyses of post-
implantation stage embryos, in which they examined the transcriptional
levels of the genes H19 (Ferguson-Smith et al., 1993), Igf2 (Ferguson-Smith et
al., 1991; Sasaki et al., 1992), and Snrpn (Cattanach et al., 1992) in maternally-
disomic mice, and of H19 and Igf2 in paternally-disomic mice (McLaughlin et
al., 1996). In all of these cases the expression levels of the genes correlated
with the parental origin of the alleles in question, suggesting that the sole
determinant of imprinted gene expression is a parent of origin-specific
modification made during gametogenesis, such as DNA methylation. Studies
of post-implantation androgenotes showed that the maternally-expressed
genes H19 (Sasaki et al., 1995; Walsh et al., 1994) and Igf2r (Walsh et al., 1994)
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were not expressed, while in parthenogenotes the paternally-expressed gene
Igf2 was not expressed (Spindle et al., 1996; Walsh et al., 1994).
All of these studies suffer from their inability to distinguish the allelic
origin of expression, and thus any attribution of overexpression to biallelic
expression is a potentially fallible conclusion. Recently, a quantitative,
sensitive assay of allelic expression levels in androgenotes and
parthenogenotes revealed a dosage-dependent correspondence between
parental origin of an allele of Snrpn and its expression level, regardless of
ploidy of the embryo (Szab6 and Mann, 1996). This careful analysis lends
strong support to the hypothesis that it is solely the deregulated, biallelic
expression of imprinted genes which causes the developmental defects of
uniparentally-derived embryos and mice and humans with UPD of specific
chromosomes.
Imprinted genes show allele-specific methylation
DNA methylation has long been proposed to constitute the molecular
mark which distinguishes the two alleles of imprinted genes (Mann and
Lovell-Badge, 1984). Evidence for DNA methylation constituting the
imprinting mark includes differential methylation of imprinted transgenes
(Chaillet et al., 1991; Reik et al., 1987; Sapienza et al., 1987; Swain et al., 1987)
and the imprinted endogenous genes H19 (Bartolomei et al., 1993; Tremblay
et al., 1995), Igf2r (St6ger et al., 1993), Xist (Ariel et al., 1995; Zuccotti and
Monk, 1995), Igf2 (Sasaki et al., 1992), p5 7KIP2 (Hatada and Mukai, 1995), Snrpn
(Glenn et al., 1996), and U2afl-rsl (Hatada et al., 1995). In fact, the imprinted
genes U2afl-rsl (Hatada et al., 1993) and Cdc25Mm (Plass et al., 1996) have been
cloned based upon the methylation differences between the two alleles in
adult mouse DNA. Rigorous analyses now need to be performed upon
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imprinted genes in parthenogenotes and androgenotes to see if biallelic
methylation of these genes is responsible for directing their biallelic
expression, as experiments described below would predict.
Establishment and maintenance of genomic imprints
The acquisition and developmental propagation of the methylation
mark has been described in detail for the three imprinted genes H19, Igf2, and
Igf2r, and for Xist, a partially-imprinted gene encoded at the center for X
chromosome inactivation. H19, Igf2r, and Xist all undergo sex-specific de
novo methylation during gametogenesis which is believed to mark the
alleles so that imprinted expression can be established after fertilization. The
area of an imprinted gene which receives this "primary imprint" is
subsequently referred to as an "imprinting box" (Barlow, 1995). Importantly,
the allele-specific methylation differences in these imprinting boxes are
resistant to the wave of global demethylation during cleavage and the
subsequent wave of global de novo methylation before gastrulation
(Bartolomei et al., 1993; Brandeis et al., 1993; St6ger et al., 1993; Tremblay et al.,
1995). This assures that the methylation mark imposed on the two alleles of
imprinted genes during gametogenesis remains unaltered during
development and, therefore, distinguishes the two alleles in each cell of the
organism.
H19: H19 is expressed from the maternal allele, and it acquires paternal-
specific methylation in a region upstream of its promoter during
spermatogenesis (Tremblay et al., 1995). The cognate region in the imprinted
human homologue of H19 also acquires paternal-specific methylation
patterns, despite a lack of any sequence homology between these two regions
(Jinno et al., 1996). The sequences in both species display a tandem array of
repeated sequences, though these sequences are not homologous to one
another. The two regions remain completely unmethylated in oocytes, so
that the zygote already displays a parent-specific difference in methylation
status at the two alleles. During post-implantation development, the paternal
allele of H19 acquires extensive methylation throughout its coding sequence,
and this is termed the secondary imprint (Bartolomei et al., 1993; Brandeis et
al., 1993; Ferguson-Smith et al., 1993).
The gene function of H19 remains mysterious. The gene is highly
conserved between mouse and human, and it lacks an open reading frame
(Brannan et al., 1990). Gene knockout studies have shown that H19 controls
in cis the expression of two paternally-expressed imprinted genes that are
located upstream, Igf2 and Ins-2 (Leighton et al., 1995a). In mice lacking the
H19 gene, a maternally-transmitted deletion results in the aberrant
transcription of Ins-2 and the aberrant methylation and transcription of Igf2
(both from the maternal allele). Another disruption experiment has shown
that the transcription of all three genes is dependent on the presence of two
enhancer elements located downstream of the three genes (Leighton et al.,
1995b). Transgenic experiments examining H19 imprinting at ectopic loci
have identified the imprinting box and the first exon as being crucial for
establishment of transgene imprinting (Elson and Bartolomei, 1997; Pfeifer et
al., 1996). These experiments indicate that imprinting of H19 is established
and controlled by the imprinting box. When the imprinting box is
methylated, as on the paternal allele, H19 expression is shut off and the
neighboring imprinted genes Ins-2 and Igf2 are able to utilize the two
downstream enhancers for transcription. When H19 is unmethylated, it
"competes" successfully for these enhancers, leaving Igf2 and Ins-2 inactive.
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Igf2: As mentioned above, the expression of Igf2 is controlled by H19
expression. Igf2 does not possess a region which becomes differentially
methylated in the gametes (Brandeis et al., 1993). However, a 1.5-kb region
upstream of the first Igf2 promoter has been shown to display a secondary
imprint acquired during embryogenesis (Brandeis et al., 1993; Feil et al., 1994;
Sasaki et al., 1992), in which the paternal allele is on average more
methylated.
Igf2r: The maternally-expressed gene Igf2r (St6ger et al., 1993) acquires a
maternal-specific methylation mark (the primary imprint) during oogenesis.
As with H19, Igf2r acquires an additional secondary imprint during pre-
implantation development, which is on the paternal allele and in the
promoter region (Brandeis et al., 1993; St6ger et al., 1993). Curiously, the
human homologue of Igf2r is not imprinted, despite the fact that it displays a
conservation of the methylation patterns seen in the mouse imprinting box
(Smrzka et al., 1995).
Xist: This gene shows imprinted expression only in preimplantation
embryos and extraembryonic tissues (Kay et al., 1993). Like Igf2r, Xist acquires
a maternal-specific primary imprint during oogenesis(Ariel et al., 1995;
Zuccotti and Monk, 1995). In contrast to H19 and Igf2r, the methylation
imprint of the maternal Xist allele is erased after implantation in cells of the
embryonic lineage, and either the paternal or the maternal allele becomes
methylated at the time of X inactivation (Norris et al., 1994).
Other phenomena associated with genomic imprinting
Several other observations of imprinted genes deserve mentioning, for
they may explain either the mechanism of monoallelic expression or the
evolutionary origin of genomic imprinting in mammals.
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a) Fluorescent in situ hybridization analysis has suggested
asynchronous replication times of the two alleles of many imprinted genes
(Kitsberg et al., 1993; Knoll et al., 1994), and this asynchrony may depend upon
imprinted transcriptional activity within a given cell type (Kawame et al.,
1995).
b) The observation of repeated sequences at many imprinted genes,
which resemble the long terminal repeats of retroviral-like sequences, has led
to the hypothesis that the molecular means of imprinting may have arisen
from the use of DNA methylation as a host defense response (Neumann et
al., 1995). This argument was supported by the fact that insertions of a
defective retroviral intracisternal particle at the agouti locus leads to partial
genomic imprinting of that gene's expression (Duhl et al., 1994; Michaud et
al., 1994).
c) Imprinted genes are also claimed to possess fewer and smaller
introns than normal (Hurst et al., 1996). The two previous assertions (b and c)
were challenged on the basis that exceptions to the rule exist and that the
number of genes available to analyze is too small (Haig, 1996).
d) Imprinted genes are found to cluster together on various
chromosomes. The imprinted genes H19, Igf2, Ins2, Mash2 and p57KIP2 all lie
on distal chromosome 7 in the mouse (Giddings et al., 1994; Guillemot et al.,
1995; Hatada and Mukai, 1995; Zemel et al., 1992) and H19 seems to control the
imprinted gene expression of at least Igf2 and Ins2 (Leighton et al., 1995a, b).
A 400-kb segment of human chromosome 15q, deletions in which cause both
Prader-Willi and Angelman syndrome, contains the five imprinted genes
SNRPN, ZNF127, PARI, PAR5, and IPW (Lalande, 1996).
e) Finally, imprinted genes bear some other curious features, such as
sex-specific differences in recombination rates (Paldi et al., 1995) and a late-S-
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phase physical association between the imprinted domains of homologous
chromosomes (LaSalle and Lalande, 1996). Any of these traits may reflect the
mechanism by which monoallelic expression is established or maintained,
but their relevance to the establishment of imprinting patterns is entirely
unclear, and will not be discussed further.
III. Genomic Imprinting and DNA Methyltransferase
DNA methylation controls both the initiation and maintenance of imprinted
gene expression
Strong evidence for methylation being crucial for the maintenance of
monoallelic expression of imprinted genes was provided by the analysis of
Dnmt mutant embryos (Beard et al., 1995; Li et al., 1993). Hypomethylation of
the DNA in mutant embryos or ES cells resulted in loss of monoallelic
expression, either in the activation of the inactive H19 and Xist alleles or in
the inactivation of the active Igf2r and Igf2 alleles. These experiments did
not, however, provide insights into the role of methylation in the
establishment of genomic imprinting during gametogenesis.
In the second chapter I address the process by which the allele-specific
methylation of imprinted genes is acquired (Tucker et al., 1996a). I expressed
the wild-type Dnmt cDNA in homozygous Dnmt mutant ES cells to assess
whether this would restore the low methylation levels of the genomic DNA
to normal. While normal methylation levels of non-imprinted DNA were
reestablished, imprinted genes were neither remethylated nor appropriately
expressed. However, passage of the remethylated ES cells through the germ
line restored normal methylation and expression to all imprinted genes
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analyzed. These results support the primary role that methylation plays in
the control of imprinted gene expression. The data are consistent with the
presence of distinct de novo DNA methyltransferase activities during
oogenesis and spermatogenesis which specifically recognize imprinted genes
but which are absent in the post-implantation embryo and in ES cells.
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Chapter One
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Much evidence indicates that in vertebrates the methylation of DNA at
cytosine residues affects gene transcription (Yeivin and Razin, 1993).
Methylation is believed to be important in a variety of biological processes,
including embryonic development, genomic imprinting, and cancer (Barlow,
1995; Jones et al., 1992). A single gene (Dnmt) encoding a DNA (cytosine-5)-
methyltransferase (MTase) has been cloned from mammalian cells (Bestor et
al., 1988). MTase shows a marked preference for hemimethylated DNA
(Gruenbaum et al., 1982), suggesting that its function is to maintain the
methylation status of newly replicated DNA. The enzyme consists of an
amino-terminal regulatory domain followed by a 500-amino acid domain
assumed to contain the catalytic center, due to its homology to cytosine-
methylating bacterial type II restriction methyltransferases (Leonhardt and
Bestor, 1993).
The crucial importance of methylation in development, genomic
imprinting, and cancer was demonstrated by the targeted mutation of the
Dnmt gene in embryonic stem (ES) cells (Li et al., 1992). Mice homozygous for
the mutation die at midgestation; homozygous mutant ES cells proliferate
normally with their genomic DNA highly demethylated but die upon
differentiation (Lei et al., 1996). Imprinted genes display parent-specific
monoallelic expression, and DNA methylation has been proposed to
constitute the molecular mark that distinguishes the two alleles (Barlow,
1995). Strong support for this notion was provided by the loss of monoallelic
expression of these genes in homozygous Dnmt mutant embryos or ES cells
(Li et al., 1993). Furthermore, a large body of evidence links hypo- and
hypermethylation of genomic DNA to cancer progression (Laird and Jaenisch,
1994). A direct correlation between DNA methylation and intestinal
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neoplasia was demonstrated in mice expressing different levels of MTase
(Laird et al., 1995).
The work presented in this chapter (see also Appendix A) used the
complementation of the Dnmt mutation as an assay to define the sequences
encoding a functional MTase. Previous reports of high expression of
functional MTase in transient transfections (Czank et al., 1991; Glickman and
Reich, 1994) contrasted with the inability to achieve high expression levels in
stable transfection experiments. In fact, only one report described high levels
of MTase expression in stably transfected clones which, however, displayed a
transformed phenotype (Wu et al., 1993). I found that the published cDNA
was incapable of expressing wild type levels of MTase and complementing the
Dnmt mutation. A construct containing a previously reported (Rouleau et
al., 1992) Dnmt promoter fused to the Dnmt cDNA also failed in this assay. In
contrast, wild type levels of Dnmt expression were obtained after targeting the
published cDNA to its cognate locus, where expression of the full-length
cDNA from its cognate promoter fully restored MTase function to ES cells
(Tucker et al., 1996). This result suggested that sequences upstream of the
previously identified initiation codon were crucial for stable and functional
expression of the enzyme. In this chapter I report a previously unidentified
amino-terminal open reading frame which extends the coding capacity of the
construct by up to 171 amino acids. Expression of the full-length Dnmt cDNA
in mutant ES cells restored both normal methylation levels and the capacity
to form teratomas, indicating a crucial role of the amino-terminal domain in
normal enzymatic activity.
To establish stable wild type and Dnmt mutant cell lines expressing
recombinant MTase, four different expression constructs carrying the Dnmt
cDNA were created. The ubiquitously-expressed Pgk-1 promoter was used in
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pMT10 and the human EF-1a promoter in pMT40 to direct expression of the
Dnmt cDNA. A synthetic intron was inserted into pMT10 to increase gene
expression levels, creating pMT20. pMT30 was derived from pMT10 by
replacing the Pgk-1 promoter and the first 180 bp of the Dnmt cDNA with a
4.7-kb Dnmt genomic fragment containing a previously reported Dnmt
promoter (Rouleau et al., 1992) and the excised 180 bp of cDNA, restored in its
genomic context.
The four constructs were separately co-transfected into wild type Dnmt
J1 ES cells (Li et al., 1992) and the homozygous mutant Dnmts/s (Lei et al.,
1996) and Dnmtn/n cell lines (Li et al., 1992). Only low levels of the Dnmt
cDNA were expressed in wild type or mutant ES cells stably transfected with
any of these constructs. To test the hypothesis that the low mRNA expression
was caused by the protein product of the Dnmt expression constructs being
detrimental to cells, a construct was designed such that translation of the
Dnmt cDNA would end prematurely, producing truncated and possibly
inactive peptides. In contrast to a typical clone carrying the wild type cDNA,
high levels of RNA were produced in 4 / 8 clones carrying the mutant cDNA
construct. These results are consistent with a detrimental effect of the protein
produced from the original expression constructs resulting in selection
against cells expressing high levels of the truncated Dnmt cDNA.
Both the low expression levels in cells carrying the truncated cDNA in
stably transfected ES cells and the restoration of high levels of expression
from constructs containing an in-frame stop codon in the ORF, were
consistent with a truncated polypeptide being produced from the cDNA,
translation of which may be detrimental to ES cells. By 5' RACE and
screening of a Dnmt-specific cDNA library, I isolated additional upstream
cDNA sequence comprising two exons separated by an 11.5-kb intron.
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Examination of the genomic sequence surrounding this new primary exon
revealed an uninterrupted open reading frame that begins upstream of and
continues throughout the two new exons, extending the published coding
sequence by 171 codons. Three new in-frame ATG codons were found in this
ORF.
To test the possibility that the newly-discovered cDNA sequence would
allow normal expression and MTase functioning in vivo, a mini-gene
expression construct was made and stably transfected into Dnmt mutant ES
cells. pMT50 was made by insertion of a 5.0-kb region of the Dnmt locus that
included the first exon into pMT30. pMT30 contained the previously
reported Dnmt promoter (Rouleau et al., 1992) but had been shown not to
function in Dnmt mutant ES cells. pMT50 resulted in the Dnmt cDNA fused
3' to a 9.7-kb piece of genomic Dnmt sequence that ended in the fourth exon
and included 3.6 kb of genomic sequence upstream of the first exon, the two
new exons reported above, three introns, and the beginning of the fourth
exon.
Dnmts/s cells were electroporated with the linearized construct. 7/12
clones examined showed random integration into the genome and normal
levels of genomic methylation, as compared to wild type cells. All clones
carrying an intact transgene displayed equivalent methylation profiles at
repetitive gene sequences and Xist. The imprinted genes H19 and Igf2r,
however, were not remethylated, as reported previously for a smaller, similar
Dnmt cDNA-containing plasmid that was targeted to the endogenous Dnmt
locus (Tucker et al., 1996). Western blot analysis revealed a range of MTase
levels from 10-100% that of a wild type allele, with the minigene-encoded
enzyme co-migrating with wild type MTase.
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Three of the rescued lines were used to induce teratomas by
subcutaneous injection into syngeneic male host animals. While the
parental mutant cells failed to form palpable teratomas within 3-4 weeks (n =
0 / 12), the rescued ES cells induced teratoma formation at a similar rate (n = 9
/ 10) as the wild type J1 ES cells (n = 6 / 6). Histological analysis of these
teratomas revealed a wide variety of differentiated cell types, consisting
mostly of mature neural tissue and including discrete patches of epithelial
tissue, cartilage, trophectoderm, osteoid, and a relative deficiency of striated
muscle (data not shown). From these results we conclude that the additional
sequences uncovered above are necessary for functional activity of MTase in
vivo.
The first exon of Dnmt was found to lie within a CpG island, as defined
by Bird (Bird, 1986). Our results are not in agreement with the localization of
the Dnmt promoter localized upstream of exon 3, as reported by Rouleau et
al. (1992). Expression from this promoter would produce a truncated MTase
which is detrimental to stably transfected cells, and Dnmt expression
constructs utilizing this promoter failed to effect complementation in Dnmt
mutant cells. Instead we suggest that a promoter contained within the pMT50
construct represents the functionally relevant transcriptional start site.
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Imprinted genes display parent-specific monoallelic expression
(Barlow, 1995; Surani, 1994), although often not at all developmental stages
(Szabo and Mann, 1995). Genes which are predominantly expressed from the
maternal allele include Igf2r (Barlow et al., 1991) and H19 (Bartolomei et al.,
1991), while Igf2 (DeChiara et al., 1991) is expressed paternally. DNA
methylation has been proposed to constitute the molecular mark which
distinguishes the two alleles of imprinted genes. Evidence for DNA
methylation constituting the imprinting mark includes differential
methylation of imprinted transgenes (Chaillet et al., 1991; Reik et al., 1987;
Sapienza et al., 1987; Swain et al., 1987) and imprinted endogenous genes.
The acquisition and developmental propagation of the methylation mark has
been described in detail for the two imprinted genes H19 and Igf2r. The H19
gene acquires paternal-specific methylation in a region upstream of its
promoter during spermatogenesis (Tremblay et al., 1995), while Igf2r (St6ger
et al., 1993) acquires a maternal-specific methylation mark during oogenesis.
Importantly, the allele-specific methylation differences in these "imprinting
boxes" are resistant to the wave of global demethylation during cleavage and
the subsequent wave of global de novo methylation before gastrulation
(Bartolomei et al., 1993; Brandeis et al., 1993; St6ger et al., 1993; Tremblay et al.,
1995). This assures that the methylation mark imposed on the two alleles of
imprinted genes during gametogenesis remains unaltered during
development and, therefore, distinguishes the two alleles in each cell of the
organism.
Strong evidence for methylation being crucial for the maintenance of
monoallelic expression of imprinted genes was provided by the analysis of
Dnmt mutant embryos (Li et al., 1993; Beard et al., 1995). Hypomethylation of
the DNA in mutant embryos or ES cells resulted in loss of monoallelic
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expression, either in the activation of the inactive H19 allele or in the
inactivation of the active Igf2r and Igf2 alleles. These experiments did not,
however, provide insights into the role of methylation in the establishment
of genomic imprinting during gametogenesis.
In this chapter I address the process by which the allele-specific
methylation of imprinted genes is acquired. I have expressed the wild type
Dnmt cDNA in homozygous Dnmt mutant ES cells to assess whether this
would restore the low methylation levels of the genomic DNA to normal. To
assure correct quantitative and developmental expression of the construct, the
cDNA was inserted by homologous recombination into the cognate Dnmt
locus upstream of the mutation. Homologous insertion of this hybrid vector
was expected to leave all upstream control elements of the gene intact, leading
to restoration of normally-regulated MTase expression. By Southern blot
analysis, 73 / 182 puromycin-resistant clones had undergone homologous
recombination events in which a single copy of the plasmid integrated at a
single allele. Northern blot analysis showed that the inserted cDNA was
transcribed at a level and size comparable to that of the endogenous allele. All
73 homologous recombinants examined showed near-complete genomic
remethylation, as assayed using two repetitive sequence probes: a Moloney
Murine Leukemia Virus (MoMuLV) cDNA and a minor satellite centromeric
repeat.
I tested whether restoration of genomic DNA methylation levels in
mutant ES cells carrying the Dnmt cDNA would rescue the lethal mutant
phenotype, as exhibited by a failure to differentiate normally in vitro, to form
teratomas, and to donate to late-gestation and adult chimeras made with wild-
type hosts. Rescued ES cells were capable of differentiating normally in all
three assays, in contrast to the parental Dnmt mutant cells.
45
The restoration of wild-type methylation levels and consequent
transcriptional inactivation was observed for the single-copy gene Xist. The
partially methylated pattern seen in normal male ES cells (Beard et al., 1995)
was restored to the same degree in the rescued ES cells. The remethylation of
Xist, coupled with the functional complementation assays, suggests that the
methylation of all or most other non-imprinted genes is fully restored.
The imprinted genes H19 and Igf2r were not remethylated after
introduction of the Dnmt cDNA into the mutant ES cells. The regions
examined for methylation show a gamete-specific methylation difference and
are believed to constitute the primary imprinting mark (Barlow, 1995). The
methylation of these regions and expression status of these genes in rescued
ES cells was identical to that seen previously in Dnmt mutant ES cells and
embryos (Li et al., 1993). Furthermore, hypomethylation persisted in ES cell-
derived fibroblasts isolated from chimeras, and methylation was restored to
normal only after germline transmission. Normal expression patterns of all
imprinted genes was observed only after passage through the germ line.
Our results show conclusively that passage through the male germ line
is necessary to obtain the allele-specific methylation mark on at least one
imprinted gene, H19. This suggests the existence of a male-specific de novo
methyltransferase activity which may specifically recognize all paternally-
modified imprinted genes. Presumably a female-specific de novo
methyltransferase activity exists, which would be active during oogenesis and
would be expected to recognize maternally-imprinted genes such as Igf2r. We
have no evidence whether the gamete-specific activities are encoded by
separate genes, are due to modification of the maintenance MTase or the
separately-encoded de novo methyltransferase activity (Lei et al., 1996), or are
reflective of a change in chromatin structure affecting substrate accessibility.
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Conclusion
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In order to establish a model of ectopic DNA cytosine
methyltransferase (MTase) expression, I have attempted to express the Dnmt
gene as a transgene in embryonic stem (ES) cells homozygous for a Dnmt
gene disruption. Chapter One reports the cloning of the 5' end of the Dnmt
mRNA and subsequent expression of the full-length Dnmt cDNA in Dnmt
mutant ES cells with a construct employing the endogenous Dnmt promoter
to drive transcription. Only when the full-length cDNA was employed could
the Dnmt gene product rescue the hypomethylation phenotype of Dnmt
mutant cells, causing a rescue of the inability of the mutant cells to
differentiate. Chapter Two details the functional consequence of MTase
expression in the background of the completely hypomethylated Dnmt
mutant genome. While normal methylation levels of non-imprinted DNA
were reestablished, imprinted genes were neither remethylated nor
appropriately expressed. However, passage of the "rescued" ES cells through
the germ line restored normal methylation and expression to all imprinted
genes analyzed. The data are consistent with the presence of distinct de novo
DNA methyltransferase activities during oogenesis and spermatogenesis
which specifically recognize imprinted genes but which are absent in the post-
implantation embryo and in ES cells.
As the main findings of these two projects are discussed at length in
their respective chapters, the remainder of this conclusion will be spent in
discussing the experimental utility of rescued ES cell lines for investigating
the evolution of genomic imprinting in mammals. A very attractive model
to explain the origin of this phenomenon proposes it to be a nonessential,
evolutionarily-recent addition to the basic mammalian developmental
program. Rescued ES cells lacking methylation at imprinted loci are
hypothesized to reflect this "pre-imprinted" genome, and may consequently
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have a normal developmental potential. Rescued cells can best be compared
with that of cells derived from androgenetic and parthenogenetic embryos.
Like the rescued ES cells, these uniparentally-derived embryonic cells show
deregulated, biallelic expression of imprinted genes. Chimeras made between
wild-type embryos and uniparental embryonic cells are generally inviable,
showing highly skewed and complementary distribution of the uniparental
cells to different tissues of the chimera. If genomic imprinting is nonessential
for development, however, the tissue-specific distribution of rescued ES cells
in chimeras should be as widespread as that of wild-type ES cells. Published
research which is relevant to this question shall be discussed first, followed by
an outline of current theories explaining the evolution of genomic
imprinting and the experiments (currently underway) which will address
these theories.
Tissue-specific distribution of parthenogenetically- and androgenetically-
derived cells in chimeras made with wild-type hosts
The ability of cells derived from parthenogenetic (PG) and androgenetic
(AG) embryos to contribute to differentiated tissues in the embryonic and
adult mouse has been analyzed by the production of chimeras using wild-type
embryos as hosts (reviewed in Fundele and Surani, 1994). Because of their
ease of production (Cuthbertson, 1983), aggregation chimeras made with PG
cells were the most extensively analyzed, though later analyses with PG ES
cells confirmed these results (Allen et al., 1994). PG cells were found in both
the inner cell mass and trophectoderm of the blastocyst (Clarke et al., 1988;
Thomson and Solter, 1989). PG cells were sequentially eliminated, first from
the extraembryonic trophoblast, then the yolk sac endoderm, and finally the
yolk sac mesoderm, to the extent that they were completely absent from the
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extraembryonic tissues at mid-gestation (Clarke et al., 1988; Nagy et al., 1987;
Surani et al., 1988; Thomson and Solter, 1988). From midgestation, the
number of PG cells in the fetus decreased steadily (Bender et al., 1995; Fundele
et al., 1990; Nagy et al., 1987). In the adult chimera, PG cells contributed most
extensively to tissues of ectodermal origin (e.g. brain, epidermis, dorsal root
ganglia) (Fundele et al., 1989; Fundele et al., 1990; Nagy et al., 1989) and to the
ovary, including oocytes capable of supporting normal development upon
fertilization (Stevens, 1978). Relative deficiencies were seen in all other
organs, especially the liver and pancreas (Fundele et al., 1989; Fundele et al.,
1990; Nagy et al., 1989).
Most strikingly, PG cells were completely excluded from skeletal
muscle, though not from cardiac or smooth muscle (Fundele et al., 1989;
Fundele et al., 1990; Nagy et al., 1989). More extensive analysis of this
phenotype revealed that by 13 dpc, any PG cells found in chimeric muscle
blastemas were excluded from the myogenic lineage (Bender et al., 1995). As
PG cells contribute well to the myotome of 11 dpc chimeras (Fundele et al.,
1994), and as occasional PG cell-derived myotubes were observed (Bender et
al., 1995), it is unclear whether the defect lies in an impaired ability of PG cells
to form myoblasts or for those myoblasts to fuse.
Reflecting the differences in developmental potential of
parthenogenotes and androgenotes, AG cells showed a distribution in
chimeras made with wild-type hosts which was strikingly complementary to
PG cells. Initial studies indicated that AG cells were allocated mostly to the
extraembryonic tissues of pre-implantation embryos (Surani et al., 1988;
Thomson and Solter, 1988). Interestingly, PG cell <-> AG cell chimeras
displayed this complementary lineage segregation without rescuing
embryonic lethality (Surani et al., 1987). Donation of AG cells to the embryo
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proper was not observed until ES cells derived from androgenotes were used
to make chimeras (Mann et al., 1990). AG cells could populate all cell types
examined, sometimes to a high degree of chimerism (Barton et al., 1991;
Fundele et al., 1995a). A disproportionate representation of AG cells was
found in mesodermally-derived tissues, especially in the heart and skeletal
muscle, with low contribution in the brain and gonad of either sex. Whether
AG cells can pass through the germline is of great interest, but the neonatal
fatality of all AG chimeras produced to date prevents this from being known.
Most strikingly, severe abnormalities of skeletal elements, particularly of the
rib cage cartilage, were noticed, which may explain the high incidence of early
postnatal lethality (Barton et al., 1991; Mann et al., 1990; Mann and Stewart,
1991). Only chimeras with a low percentage of AG cells survived this early
postnatal period. In contrast to PG cells, AG cells displayed an increased
proliferation rate in all examined tissues of 13 dpc chimeras, but this
difference diminished later in embryogenesis and was not reflected in an
increased representation in the relevant tissues (Fundele et al., 1995b).
A brain-specific difference in the relative distributions of AG and PG
cells is of special interest. Reflecting trends already established by 10.5 dpc, PG
cells in adult chimeras were completely excluded from the hypothalamus and
enriched in the frontal cortex, striatum and hippocampus (Allen et al., 1995).
Just the opposite distribution was seen for AG cells in the brain (Keverne et
al., 1996). The authors also claimed that chimeric males made with PG cells
were more aggressive than wild-type counterparts (Allen et al., 1995).
Many authors have noted that PG cells in a chimera caused a decrease
in body size that correlated with the extent of PG cell contribution (Fundele et
al., 1989; Fundele et al., 1990; Paldi et al., 1989; Surani et al., 1977). Whether
this size difference can be explained by a decrease in proliferation potential is
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controversial. Proliferation of PG cells, compared to wild-type cells in the
same chimera, was seen to be only slightly impaired in a few tissues in pre-
(Bender et al., 1995) and post-natal chimeras (Jdigerbauer et al., 1992). As well,
overall contribution of PG cells to chimeras was not seen to decrease with age
postnatally (Nagy et al., 1989). In contrast, AG cell-bearing chimeras were both
larger and longer than normal litter mates (Barton et al., 1991). Some
evidence exists that AG cells do proliferate better than wild-type cells in the
same chimera (Fundele et al., 1995b). These findings are suggestive in that
they may help explain the relative abilities of parthenogenotes and
androgenotes to develop as embryos. They also suggest a fundamental role of
genomic imprinting in influencing rates of growth during development,
though the importance of this influence on growth rates to general
development is under much debate (see below).
The expression and methylation patterns of imprinted genes are deregulated
in PG and AG cells
Imprinted gene expression was examined in differentiated cultures of
normal and UPD-derived ES cells, and results roughly paralleled that seen in
embryos. In observations of later passage embryoid bodies (Allen et al., 1994;
Szab6 and Mann, 1994), Igf2 expression was low to undetectable in PG ES cells,
while Igf2r expression wasn't observed in AG ES cells. H19 was expressed in
both cell types, however (Allen et al., 1994; Szab6 and Mann, 1994).
Comparison of these results both within and between reports is difficult,
however, because the various differentiation techniques delivered conflicting
results. Regions known to be differentially methylated in Igf2r, Igf2, and H19
were examined after in vitro differentiation (Feil et al., 1994; Szab6 and Mann,
1994). The methylation patterns were found to fall in a spectrum which
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correlated with the parental derivation of the cells (e.g. paternally-methylated
genes showed increased levels of methylation in AG ES cells, compared to
wild-type and PG ES cells). The examined regions for the most part were ones
which receive secondary imprints, and those imprinting boxes which were
examined did not show a bimodal methylation pattern (i.e. biallelically
methylated or unmethylated). Interestingly, co-expression of Igf2 and H19
was found in ES cells of all three types, both early passage embryoid bodies
(Szab6 and Mann, 1994) and teratomas (McKarney et al., 1996). Once again,
these results are hampered by an inability to distinguish methylation and
expression levels of individual alleles. The results of these experiments
indicate that in uniparentally-derived ES cells imprinting operates primarily
as predicted from the uniparental origin of the cells, but other factors such as
passage number, clonal variation and possible loss of imprinting patterns
during ES cell derivation can influence methylation patterns and expression
significantly.
In conclusion, the examination of specific imprinted genes has led to
the hypothesis that aberrant expression levels of these genes cause the
multiple developmental abnormalities seen in the embryonic cells derived
from parthenogenotes and androgenotes.. The growth-promoting and
-suppressing functions of many of these genes makes them attractive
candidates to explain the growth-related abnormalities recorded in both mice
and human displaying UPD for specific chromosomal segments. It must be
kept in mind, however, that most imprinted genes discovered so far are
clustered together in small imprinted gene domains. Thus, the expression of
all imprinted genes on a given chromosomal segment is presumably
deregulated in cases of UPD, so that it is very difficult to ascribe a phenotype
to the over- or under-expression of any given gene. The precise function of
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each imprinted gene in development will be best evaluated by gene
disruption experiments.
Evolutionary origins of genomic imprinting
The evolutionary origin of genomic imprinting has caused much
speculation. A simple explanation (Solter, 1988) views the necessity of equal
paternal and maternal contribution to the zygote for normal development as
a mechanism ensuring that parthenogenesis will not occur. The dangers of
parthenogenesis include the uncovering of harmful recessive alleles and the
production of dangerously invasive trophoblast (Hall, 1990). Along the same
lines, it has been proposed that the monoallelic expression of a certain
number of essential genes could act as a guard against recombination events
that are associated with neoplastic transformation (Thomas, 1995). Loss of
expression of an imprinted gene product, as a result of an aberrant
recombination event, could either be sensed indirectly or lead directly to
growth arrest. This argument would logically necessitate imprinted genes
placed randomly through the genome, which is clearly not the case. Also,
none of the three reported gene disruptions of imprinted genes is embryonic
lethal (DeChiara et al., 1990; Lau et al., 1994; Leighton et al., 1995a; Wang et al.,
1994). Finally, loss of imprinted gene expression is associated with many
tumor types, including Wilms' tumor, rhabdomyosarcoma, neuroblastoma,
and the Philadelphia-chromosome-positive leukemia (Reeve, 1995). In
contrast to this "guardian of the genome" hypothesis, the deregulation of
imprinted gene expression is at best a consequence of neoplastic
transformation, and at worst a possible cause for tumor formation!
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The Haig hypothesis: maternal and paternal genomes place conflicting
demands upon fetal growth
A much more convincing theory to explain the evolutionary origin of
genomic imprinting stems from the fact that the placental method of
development used by mammals places an inordinate demand upon the
female for resources expended in the nourishment of the growing fetus
(Moore and Haig, 1991). In mammals such as mice, in which females have a
high probability of multiple mates, it is to the advantage of females to
conserve resources during a single pregnancy so that multiple litters can be
generated in one lifetime. There are often multiple fathers within a single
litter of mice, so embryos will compete with their siblings for scarce maternal
resources. Males have an obvious advantage in maximizing the fitness of
their offspring, in comparison to those of another male. This conflict in the
interests of the maternal and paternal genomes could lead to alterations in
the expression levels of genes that influence embryonic growth rates.
This theory predicts that paternally-inherited alleles would be up-
regulated for growth-promoting genes and down-regulated for genes leading
to growth suppression. This is precisely what one observes when the
function of imprinted gene products are correlated with their expression. The
paternally-expressed gene insulin-like growth factor 2 (Igf2) encodes a secreted
growth factor (DeChiara et al., 1990), while the maternally-expressed insulin-
like growth factor 2 receptor (Igf2r) encodes a receptor which acts as a putative
"sink" for the Igf2 ligand, trapping the growth factor without transducing a
signal (Haig and Graham, 1991). Three of the four reported imprinted-gene
disruptions have shown an altered growth rate in the mutant embryos
(DeChiara et al., 1991; Lau et al., 1994; Leighton et al., 1995a; Wang et al., 1994),
and most of the products of the newly-discovered imprinted genes have
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growth-related functions (Guillemot et al., 1995; Hatada and Mukai, 1995;
Plass et al., 1996; Villar and Pedersen, 1994).
As pointed out by R. Jaenisch (1997), the specific genes which have
imprinted gene expression would depend upon the reproductive behavior of
the mammal in question, and could vary widely from species to species.
Comparisons between mouse and humans reveals lack of conservation of
imprinted gene expression, as one would expect for a function which is not
essential to the development of an organism (Kalscheuer et al., 1993; Pearsall
et al., 1996). It will be of great interest to examine the allelic expression of
imprinted genes in other mammals, especially the monotremes and
marsupials, in which the major contribution of maternal energy reserves to
the fetus occurs before fertilization and after parturition, respectively (Graves,
1996).
Is genomic imprinting necessary for development?
According to the Haig model, imprinted gene expression would have
evolved after a basic plan for vertebrate development had already been
established. The origin of monoallelic expression of a pre-existing gene could
occur, for example, through the use of a de novo DNA methylation event to
inactivate this gene upon passage through the germline of one sex. If this
gene were involved in growth enhancement, and were inactivated by
methylation in the female germ line, compensatory paternal activation of a
growth-enhancing gene may occur to counteract this initial silencing event.
Precedent for the complementarity of oppositely-imprinted genes is seen on a
gross scale in the reciprocal developmental phenotypes of parthenogenotes,
which support extensive normal embryonic development but fail to form
56
extraembryonic tissue, and androgenotes, which support extensive
proliferation of extraembryonic tissue but not of the embryo itself.
Complementarity can be seen on a gene-specific level by looking at the
analysis of gene knockout experiments. Deletion of Igf2 results in
"proportionate dwarf" mice, which are 60% smaller than wild-type
littermates (DeChiara et al., 1991). In contrast, deletion of Igf2r results in mice
which are 30% larger than normal, though they die at birth (Lau et al., 1994;
Wang et al., 1994). Perinatal lethality of the Igf2r mutation is rescued in mice
carrying both the Igf2 and Igf2r mutations, which are normal in size (Wang et
al., 1994) and fertile (Ludwig et al., 1996). Additionally, H19-deficient mice,
which are 30% larger than their wild-type littermates, are normal-sized when
crossed into the Igf2 null background (Leighton et al., 1995a). Though not
every imprinted gene can be expected to have an oppositely-imprinted
partner whose genetic interactions are directly antagonistic, as with Igf2 and
Igf2r, the sum effect of a loss of imprinted gene expression should allow
normal development of the embryo.
The ES cells which have been generated by expression of the Dnmt
cDNA in the background of Dnmt mutant cells provide an excellent reagent
for addressing the importance of imprinted gene expression in embryonic
development. As shown in Chapter Two, the imprinting boxes of both of the
imprinted genes H19 and Igf2r remained hypomethylated after expression of
the Dnmt cDNA in the background of the Dnmt mutation. Both genes, as
well as Igf2, assumed an abnormal, biallelic transcriptional profile as a
consequence of this hypomethylation, as seen before in homozygous Dnmt
mutant embryos (Li et al., 1993).
According to the Haig hypothesis, genomic imprinting evolved in
mammalian species after the basic developmental program of these species
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was established. Making the crucial assumption that DNA methylation has
been used during evolution to determine the monoallelic expression patterns
of imprinted genes, the prediction is clear. The erasure of methylation at
imprinted loci should restore their methylation status to one reflective of a
time before the evolution of genomic imprinting, and this will result in a
corresponding "pre-imprinting" transcriptional profile for every imprinted
gene. Genes such as Igf2 and Igf2r will be shut off, while genes such as H19
will be expressed from both alleles. A mouse bearing such changes should
show no developmental abnormalities, in distinct contrast to the
developmentally-compromised parthenogenotes and androgenotes.
Unfortunately, this mouse is not available, but the rescued ES cells
described in Chapter Two do have this genomic methylation profile. These
ES cells have been used to make chimeras with wild-type embryos, and their
tissue-specific distribution will be analyzed. As described above, PG and AG
cells show restricted, complementary distribution in chimeras. Specifically,
contribution to skeletal muscle is compromised in PG cells, while AG cells
show extremely limited contribution to brain tissue. If normal development
is restored after the erasure of genomic imprinting, rescued ES cells should be
able to contribute to all of those tissues that AG and PG cells respectively
cannot. Tissue-specific distribution of rescued ES cells in chimeras is being
analyzed by two methods. Firstly, organs and tissues taken from adult
chimeras are being analyzed by Southern blot to determine the fraction of
contribution from rescued ES cells. Secondly, the CHIP protocol described in
Chapter Two has been applied to embryonic germ (EG) cells which are
homozygous for the Dnmts mutation and also contain the ROSA 11 cell
marker, a lacZ gene which is ubiquitously expressed in all tissues throughout
development and early adulthood (Friedrich and Soriano, 1991). I have
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generated rescued, lacZ-expressing EG cells which will be used to analyze
contribution to fine structures such as the hypothalamus in the brain.
Preliminary results have been obtained from examination of teratomas
formed by subcutaneous injection of rescued ES cells into syngeneic host
animals. The variety of differentiated cell types in the resultant teratomas
was tabulated and compared to that seen in wild-type ES cells 1. No significant
differences were observed, with the sole exception of a relative deficiency in
striated muscle in teratomas formed by the rescued ES cells (Fig. 1). This
resembles the phenotype shown by PG ES cells in teratomas (Allen et al.,
1994), in contrast to AG ES cells, which form exclusively striated muscle in
teratomas (Mann et al., 1990).
Mice which are genetically homogenous for a given mutation are
normally made by having a mouse chimeric for ES cells containing the
desired alteration to pass that mutation through the germline. However, this
is not possible with the "epigenetic mutations" at imprinted loci observed in
the rescued ES cells, because normal methylation patterns are restored to
these genes upon passage through the germline. A technique has recently
been developed which may allow the circumvention of this problem by the
construction of a complete embryo from the rescued ES cells (Nagy et al.,
1990), allowing a definitive analysis of the developmental potential of these
cells. In this technique, a wild-type 2 cell-stage embryo is electrofused to form
a one-cell tetraploid embryo. This embryo develops in vitro to the morula
stage, when it is aggregated with ES cells. The ability of tetraploid cells to
donate to embryonic structures is extremely limited, while they have no
difficulty forming extraembryonic structures. This developmental deficiency
is complemented by the embryonic pluripotency of ES cells, which can go on
1 Tabulation performed by H. Gardner
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Fig. 1 - Differentiated cell types in teratomas made
from wild-type vs. rescued ES cells
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Teratomas were produced by injecting 3 x 106 ES cells subcutaneously into the flanks of
adult male 129/Sv mice. Wild-type J1, Dnmts/s, and 3 clones each of rescued Dnmts/s ES cells
were used. Dnmts/s cells failed to produce tumors (n = 20). pMWT-PURO refers to Dnmts/s cells
remethylated by the CHIP technique described in Chapter Two. pMT50 refers to Dnmts/s cells
remethylated by the Dnmt mini-gene vector described in Chapter One. The number of teratomas
examined is indicated in parentheses. Tumors were excised at 2-3 weeks, fixed overnight in 4%
paraformaldehyde, and prepared into haematoxylin- / eosin- stained paraffin sections. For each
tumor, several 10 Ilm sections were examined by microscopy, and quantitation of cell-type
distribution was made by noting the cell type found in consecutive ocular crosshair etchings,
averaging 35 counts in 5 randomly-chosen fields over the length of the teratoma (0.5 - 1.5 cm in
size). The category "other" includes bone, cartilage, endothelium, thyroid and fibrous tissue.
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to form the complete embryo. The Haig hypothesis predicts that rescued ES
cells should support embryonic development past the developmental block of
parthenogenotes at the 25-somite stage, so that chimeras formed in this
fashion can simply be examined for the appearance of standard
morphological markers and for levels of imprinted gene expression.
In conclusion, the Haig hypothesis has emerged as the most sensible of
the many theories put forth to explain the evolution of genomic imprinting.
This theory argues that competing concerns between males and females for
the viability of individual offspring in multi-father litters will inevitably lead
to the sex-specific activation and repression of growth-related genes. The
phenomenon of genomic imprinting can be seen as the result of a genetic
"arms race" which was imposed recently upon a basic mammalian
developmental program, and whose patterns of gene expression should vary
from species to species. Although the deregulation of individual imprinted
genes is of great consequence for both development and disease, the sum
effect of the removal of all imprinted gene expression should be a cell or
embryo with a normal developmental potential. I propose that I have created
such a reagent with the construction of ES cell lines which lack methylation
at imprinted loci, and various assays will be used to ascertain the
developmental potential of ES cells lacking an imprinted genome.
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ABSTRACT
Previous attempts to express functional DNA cytosine
methyltransferase (MTase) in cells transfected with the available
Dnmt cDNAs have met with little or no success. We show that the
published Dnmt sequence encodes an amino terminal-truncated
protein which is tolerated only at very low levels when stably
expressed in ES cells. Normal expression levels were, however,
obtained with constructs containing a continuation of an open
reading frame with a coding capacity of up to 171 amino acids
upstream of the previously defined start site. The protein encoded
by these constructs comigrated in SDS-PAGE with the endogenous
enzyme and restored methylation activity in transfected cells. This
was shown by functional rescue of Dnmt mutant ES cells, which
contain highly demethylated genomic DNA and fail to differentiate
normally. When transfected with the minigene construct, the
genomic DNA became remethylated and the cells regained the
capacity to form teratomas, which displayed a wide variety of
differentiated cell types. Our results define an amino-terminal
domain of the mammalian MTase which is crucial for stable
expression and function in vivo.
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INTRODUCTION
Much evidence indicates that in vertebrates the methylation of
DNA at cytosine residues affects gene transcription (1). Methylation
is believed to be important in a variety of biological processes,
including embryonic development, genomic imprinting, and cancer (2,
3). A single gene (Dnmt) encoding a DNA (cytosine-5)-
methyltransferase (MTase) has been cloned from mammalian cells
(4). MTase shows a marked preference for hemimethylated DNA (5),
suggesting that its function is to maintain the methylation status of
newly replicated DNA. The enzyme consists of an amino-terminal
regulatory domain followed by a 500-amino acid domain assumed to
contain the catalytic center, due to its homology to cytosine-
methylating bacterial type II restriction methyltransferases (6).
The crucial importance of methylation in development, genomic
imprinting, and cancer was demonstrated by the targeted mutation
of the Dnmt gene in embryonic stem (ES) cells (7). Mice homozygous
for the mutation die at midgestation; homozygous mutant ES cells
proliferate normally with their genomic DNA highly demethylated
but die upon differentiation (8). Imprinted genes display parent-
specific monoallelic expression, and DNA methylation has been
proposed to constitute the molecular mark that distinguishes the two
alleles (3). Strong support for this notion was provided by the loss of
monoallelic expression of these genes in homozygous Dnmt mutant
embryos or ES cells (9). Furthermore, a large body of evidence links
hypo- and hypermethylation of genomic DNA to cancer progression
(10). A direct correlation between DNA methylation and intestinal
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neoplasia was demonstrated in mice expressing different levels of
MTase (11).
The present work used the complementation of the Dnmt
mutation as an assay to define the sequences encoding a functional
MTase. Previous reports of high expression of functional MTase in
transient transfections (12, 13) contrasted with the inability to
achieve high expression levels in stable transfection experiments. In
fact, only one report described high levels of MTase expression in
stably transfected clones which, however, displayed a transformed
phenotype (14). We found that the published cDNA was incapable of
expressing wild type levels of MTase and complementing the Dnmt
mutation. A construct containing a previously reported (15) Dnmt
promoter fused to the Dnmt cDNA also failed in this assay. In
contrast, wild type levels of Dnmt expression were obtained after
targeting the published cDNA to its cognate locus, where expression
of the full-length cDNA from its cognate promoter fully restored
MTase function to ES cells (16). This result suggested that sequences
upstream of the previously identified initiation codon were crucial
for stable and functional expression of the enzyme. In this paper we
report a previously unidentified amino-terminal open reading frame
which extends the coding capacity of the construct by up to 171
amino acids. Expression of the full-length Dnmt cDNA in mutant ES
cells restored both normal methylation levels and the capacity to
form teratomas, indicating a crucial role of the amino-terminal
domain in normal enzymatic activity.
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MATERIALS AND METHODS
Vectors. Dnmt constructs used were from pMG (T. Bestor), which is
a 4934 bp Dnmt cDNA. pMT20 was made by inserting the cDNA into
a vector which contains the Pgk-i promoter and polyadenylation
sequences of ppgk::hprt (17) flanking a synthetic intron (IVS in Fig.
1A) (18). Removal of the IVS from pMT20 yielded pMT10. pMT30
was made by excising a 1357-bp Nael fragment from pMT10,
comprising the phage fl ori, the 3' end of the lacZ gene, the Pgk-1
promoter, and the first 180 bp of the Dnmt cDNA. A 4.7-kb Dnmt
NaeI genomic fragment was cloned into this site, such that the Dnmt
cDNA sequence removed from pMT10 was restored in its genomic
context. pMT40 was constructed by inserting the Dnmt cDNA
sequence into pEF-PGKhyg (gift of S. Orkin). This variant of pEF-
PGKneo (19) included a 1188-bp fragment encompassing the
promoter region of the human EF-lox gene, taken from pEF-BOS (20),
an SV40-derived polyadenylation signal, and a Pgk-l-driven hygR
gene. pMT42 was constructed from pMT40 by restriction at the
unique NsiI site in the Dnmt cDNA, destruction of the 3' overhang by
T4 DNA polymerase, and insertion of a 12-bp NheI linker (NEB),
containing amber stop codons in all three reading frames. pMT50
was made by inserting a 5.0-kb Dnmt EcoRI fragment upstream of
the Dnmt genomic region in pMT30. The inserted sequence begins
3641 bp upstream of the first exon and ends 381 bp downstream of
the testis-specific exon. The G418-selectable pPGK-RN (21) and the
puromycin-selectable pPGK-Puro (16) were made as described.
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Transfections. The J1 and the Dnmt mutant ES cell lines (7, 8) were
cultured as described (7). Each linearized construct was mixed in
five-fold molar excess with 250 ng of selectable marker and the
cationic liposome DOTAP (Boehringer Mannheim). Cells were
incubated with this mix according to manufacturer's protocol and
plated on y-irradiated murine fetal fibroblasts of the appropriate
drug-resistance. Selection went as follows: G418 (BRL) @ 200 gg/ml
(active), puromycin (Sigma) @ 2 gg/ml, and hygromycin (Boehringer
Mannheim) @ 100 ýtg/ml. Isolated colonies were picked 9-12 days
after lipofection and expanded. Nucleic acids were analyzed as
described (16). Teratomas were made as described (16).
Antibody derivation and Western blot analysis. A synthetic
peptide of the sequence NH2-CRSPRSRPKPRGPRRSK (Chiron
Mimotopes) was coupled to Maleimide-activated KLH (Pierce) and
injected into female NZW rabbits (HRP) with FCA. Boosts and bleeds
were performed using standard protocols.
Protein was analyzed from clones grown for two passages
without feeder cells. Confluent 25-cm 2 flasks of ES cells were lysed
in 2X sample buffer followed by boiling for 5 minutes and sonication.
SDS-PAGE on 8% gels were performed according to (22). Western
blot analysis was performed according to (23) using antisera HM334
at 1 / 3000 dilution and chemiluminescence (ECL Amersham).
Cloning of 5' end of Dnmt cDNA. The first technique used polyA+
RNA purified from crude tissue extracts derived from a CD1-mouse
kidney using the PolyATract System (Promega). The 5' RACE System
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(BRL) was used with 300 ng of polyA + RNA and a Dnmt-specific
primer MMT2400AS (5'-AGGGTGTCACTGTCCGACTT, located in the
fourth exon). Poly dC-tailed cDNA was subjected to 35 PCR cycles
using an annealing temperature of 570 C in a 50 tl reaction
containing 25 mM Tris-Cl (pH 8.4), 50 mM KC1, 1.5 mM MgCl 2, 40 gM
of a nested Dnmt-specific primer MMT2363AS (Fig. 3A), 40 gM of a
poly-d(GI)-anchor primer, and 10 U of Amplitaq polymerase
(Perkin-Elmer). The PCR reaction was isolated and cloned into the
pCRII vector (Invitrogen).
The second method used 400 cm 2 of confluent J1 ES cells. RNA
was prepared by extraction with guanidine thiocyanate and
centrifugation in a cesium chloride step gradient, as described (24).
RNA was passed once over an oligo(dT) 12_18-Cellulose column
(Pharmacia) as described (24). 12 gg polyA + mRNA was hybridized
with 1 gg of MMT2214AS (Fig. 3A), a Dnmt-specific primer. A cDNA
library was constructed using the TimeSaver cDNA Synthesis Kit
(Pharmacia LKB), and ligated with lambda ZAP II phage arms
(Stratagene). Recombinant phage were packaged and plated out as
described (24). 125, 000 independent clones were screened using a
probe containing Dnmt cDNA sequences upstream of the EcoRI site in
the Exon 3 (Fig. 3A). Standard procedures for hybridization, washing,
and autoradiography were observed (24). After a secondary screen,
isolated positives were picked and converted into plasmids
(Stratagene).
The first additional exon (Exon 2) was located in the genome by
identity to genomic sequence reported by Rouleau et al. (1992). The
second upstream exon (Exon 1) and the testis-specific exon were
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localized by using the cDNA fragment containing Exon 1 as a probe
for Southern blots of plasmids containing 129/Sv-derived Dnmt
genomic sequences (7).
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RESULTS
D n m t cDNA is inefficiently expressed in stable
transfections of ES cells. To establish stable wild type and D n mt
mutant cell lines expressing recombinant MTase, four different
expression constructs carrying the Dnmt cDNA were created (Fig.
lA). The ubiquitously-expressed Pgk-1 promoter (25, 26) was used
in pMT10O and the human EF-la promoter (20) in pMT40 to direct
expression of the Dnmt cDNA. A synthetic intron (18) was inserted
into pMT10 to increase gene expression levels (27), creating pMT20.
pMT30 was derived from pMT10 by replacing the Pgk-1 promoter
and the first 180 bp of the Dnmt cDNA with a 4.7-kb Dnmt genomic
fragment containing a previously reported Dnmt promoter (15) and
the excised 180 bp of cDNA, restored in its genomic context.
The four constructs were separately co-transfected into wild
type Dnmt J1 ES cells (7) and the homozygous mutant Dnmts/s (8)
and Dnmtn/n cell lines (7). The Dnmts allele is completely
inactivated whereas the Dnmt n allele is a partial loss-of-function
mutation. Cells bearing either mutation in a homozygous state stably
maintain a low level of DNA methylation (7, 8) (Fig. IC, lanes 2, 3).
Drug resistant colonies were picked after 9-12 days of selection.
Genomic DNA was extracted and analyzed by Southern blot using
Dnmt genomic and cDNA probes, which revealed high copy number
integrants with no gross rearrangements of the constructs (data not
shown). 18 positive clones were analyzed for mRNA expression by
Northern analysis, using the Dnmt cDNA as a probe. The size of the
endogenous mRNA is 5.2 kb (Fig. lB, lane 1), while the expected size
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from the transfected expression constructs was 5.1 kb. In the
Dnmts/s ES cells (lane 3) no 5.2 kb transcript was present, although
aberrant transcripts of 9.0 and 6.0 kb representing abnormal splicing
events caused by the insertion of the neomycin gene were observed
(8). Figure lB (lanes 4-9) shows a low level of expression in one-
third of the Dnmts/s clones transfected by pMT20 (lanes 4, 5), while
the other transfectants (lanes 6-9) displayed no detectable
expression. The decrease of the aberrant 6.0-kb transcript in clones
expressing low levels of pMT20 cannot be explained at present (lanes
4, 5). Quantitation of band intensities using a-tubulin as a loading
control (Fig. 1B) revealed that, in 5/18 clones, Dnmt cDNA expression
levels were 5-10% of wild type Dnmt, whereas the remaining clones
showed no detectable cDNA expression. Similarly, 23 Ji clones
transfected with the same constructs showed no significant increase
in levels of Dnmt expression over untransfected J1 ES cells (data not
shown).
To investigate whether the low Dnmt cDNA expression levels
would result in an increase in global DNA methylation, Southern blot
analysis of genomic DNA digested with HpallI, an enzyme sensitive to
the methylation of internal cytosines in its CCGG recognition
sequence, was performed. A Moloney Murine Leukemia Virus
(MoMuLV) cDNA probe which cross-hybridizes with endogenous C-
type retroviruses (28) that are heavily methylated in wild type cells
was used (Fig. IC, lane 1). DNA methylation in Dnmt mutant cells is
greatly reduced, as reflected by the increasing intensity of lower
molecular weight bands in this assay, with DNA methylation levels in
the Dnmts/s line (lane 3) lower than in the Dnmt n/ n line (lane 2).
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A slight increase in genomic methylation was detected only in those
Dnmts/s clones which had been transfected by either pMT20 (Fig. IC,
lanes 4,5) or pMT40 (data not shown) and showed plasmid
expression of >5% of the wild type allele. The extent of
remethylation was slightly higher than that seen in untransfected
Dnmt n / n cell lines. By this assay, 8/19 Dnmts/s clones containing a
Dnmt cDNA displayed partial genomic remethylation, and this
methylation level was stably maintained through five passages (data
not shown). Also, inclusion into the expression construct pMT30 of
the upstream genomic Dnmt sequences which had previously been
reported to drive transcription (15) did not lead to genomic
remethylation in Dnmt n/ n cells (0/24 clones).
Western blot analysis, using an antibody directed against the
amino terminus of the protein, indicated levels of MTase
approximately 5-10% that of wild type in pMT20-transfected clones
(Fig. 1D). Moreover, this recombinant MTase (lanes 3, 4) was shorter
by approximately 8 kilodaltons than the protein seen in J1 cells (lane
1). We conclude that, using either heterologous promoters or the
reported cognate Dnmt promoter (15), only low levels of the Dnmt
cDNA are expressed in stably transfected wild type or mutant ES
cells.
Dnmt cDNA is efficiently expressed from carboxy-
terminal truncated constructs. To test the hypothesis that the
low mRNA expression was caused by the protein product of the Dnmt
expression constructs being detrimental to cells, a construct was
designed such that translation of the Dnmt cDNA would end
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prematurely, producing truncated and possibly inactive peptides. A
stop codon-containing linker was inserted into pMT40 at the unique
Nsil site 871 bp downstream of the initial ATG in the Dnmt cDNA, to
create pMT42 (Fig. 2). This site is located in the middle of the
domain which targets MTase to sites of DNA synthesis in S-phase
nuclei (29). Translation of this message would be expected to
produce a truncated protein of 292 amino acids with neither catalytic
activity nor the ability to colocalize with replication foci. Dnmts/s E S
cells were transfected and individual colonies were examined by
Northern blot analysis. In contrast to a typical clone carrying the
wild type cDNA (Fig 2, lane 4), high levels of RNA were produced in 4
/ 8 clones carrying the mutant cDNA construct (Fig. 2, lanes 7, 8, 11,
and 12). As expected, none of the transfectants showed genomic
remethylation (data not shown). These results are consistent with a
detrimental effect of the protein produced from the original
expression constructs resulting in selection against cells expressing
high levels of the truncated Dnmt cDNA. This conclusion was
corroborated by a reduced number of clones obtained with pMT 40
containing the ORF as compared to pMT 42 carrying the stop codon:
transfection of 5x10 6 cells with the latter clone yielded 500 colonies
as compared to only 200 seen with pMT40.
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The complete Dnmt cDNA contains two additional 5'
exons which extend the open reading frame by at least 118
codons. The results described above suggested that high expression
of the Dnmt cDNA was not tolerated in transfected cells. Given the
results of Western blot analysis (Fig. ID), it appeared that the cDNA
was incomplete, encoding a truncated protein which was toxic to
cells. Therefore, we attempted to derive further upstream
sequences. First, CD1 kidney mRNA was used in 5' RACE experiments
that employed the Dnmt-specific primer MMT2400AS for first strand
cDNA synthesis. Subsequent PCR amplification of the cDNA product
with the Dnmt-specific primer MMT2363AS (Fig 3A) yielded a
product which included two additional exons.
Independently, polyA + mRNA from J1 ES cells was used for the
construction of a cDNA library. The Dnmt-specific primer
MMT2214AS (Fig. 3A) was employed for first strand synthesis, and
105 phage clones were screened with a probe containing Dnmt cDNA
sequences upstream of the EcoRI site in the third exon (Fig. 3A).
Examination of 12 clones revealed the same sequence cloned by 5'
RACE, with the longest of the clones extending the 5' RACE product
by 34 bp. In contrast to previous reports of Dnmt sequence (4, 15),
close examination identified a 141-codon extension of the published
open reading frame (ORF), including a new initial ATG 118 codons
upstream of the previously-published initial ATG (Fig. 3A).
Comparison with the published Dnmt genomic DNA sequence
(15) revealed that the new cDNA sequence comprises a 15-bp 5'
extension of the published first exon (Exon 3) and two new exons
(Exons 2 and 1, respectively; Fig. 3B). The 37-bp exon 2 is separated
96
A.
PG G VGA S VAR
-122 TAGCCAGGAGGTGTGGGTGCCTCCGTTGCGCGC
IR T P F G H S V FPH SL ALCG T CC FR LRRPLP P
-89 ATGCGCACTCCCTTCGGGCATAGCATGGTCTTCCCCCACTCTCTTGCCCTGTATGGTACATGCTGCTTCCGCTTGCGCCGCCCCCTCCC
I G FR A R E K A GV S F R A V L S S A T C K P A R T A P A
+1 AATTGGTTTCCGCGCGCGCGAAAAAGCCGGGGTCTCGTTCAGAGCTGTTCTGTCGTCTGCAACCTGCAAGATGCCAGCGCGAACAGCTCCAGCC Murne
11 111Il II II IIIIII
ccggcgcgtaccgccccagcc Human
10 20 20T30
R V P A L A S P A G S L P D H V R R R L K D L E R D G L T E K
95 CGAGTGCCTGCGCTTGCC-TCCCCGGC -AGGCTCGCT-CCCGGACC CGCAGGC GCTCAAAGACTTGGAAAGAGATGGCTTAACAGAAAAG
II 11111 I IIIIII IIII III I IIII11111111111 11 1111111111111III ll IIIIIIIII II I11111111111111
22 cgggtgcccacactggccgtccc-ggccat -ctcgctgcccg-acgatgtccgcaggcggctcaaagatt tggaaagagacagcttaacagaaaag
T V I D S
ECVREKLNLL H E FLOTE I KSO LC L E T K L H K E
188 GAGTGTGTGAGGGAGaaattaaacttactgcat aattcct caaacagaataaaaagccagtgtgt actt ggaaaccaaattacataaaag
II 1111111 111111111 11 1 11 11111 11111111111 11 I IIIII 111 111 11111111111111111
115 gaatgtgtgaaggagaaattgaatctcttgcacgaatttctgcaaacagaaatoaagaatcagttatgtgacttggaaaccaattacgtaaagaa
K N R
30 40
E L S E E G Y L1 A  K V K S L L N K D L S L E N G T H T L T 0 K A N
284 gaattatctg agaaggctaccgctaaa•tcaagtccctct aataaggatttgtccttggagaacggaacacacactctcactcaaaagccaac
IIIII i I I II IIII III II I 11111 IIIII  111 111111111 I I II II I III III
211 gaattatccgaggagggctacctggctaaagtcaaatccc tt aaaaagatttgtcct tggagaacggtgctcatgcttacaaccgggoagtgaat
A AY NREV
G C P AN G S R P T W R A E nMl 2
383 ggttgtcccgccaacggg-----------------agccggccaacctggagagcagaaa'tggcagoctcaaatagatccc gatccagg cccaa cc
II III I 111111 1111 I IIII I 1111
310 ggacgtctagaaaacgggaaccaagcaagaagtgaagcccgt ------- agagtgggaatg
R LE N OAR SEAR V G
B. 10 20 30 40
ATG
Somatic •,
splicing
Testis-
specific splicing
0 600 1200 in lAh
Figure 3
I I I I I ;.m.1 "" i I I I1 1
C pG I I I 11 IIIIIIIIIIIIIIIII 1111 11 l IIII I I I i11111 I | II III l 1
G pC II 111111111111111 III IIIIII IIIIIIIIIi III III 1 11 li|111 II IIIIII 11111 ||I i nI I Il l1111111 1111111 |I l lIII I l i ii I
from the 150-bp exon 3 by a 767-bp intron, while exon 1 lies 11.5
kb upstream of exon 2. Exon 1 was found in the center of a CpG
island (Fig. 3B) and hence provides the Dnmt gene with the typical
elements of a housekeeping gene. Examination of the genomic
sequence around the new primary exon revealed a continuation of
the ORF for another 122 bp upstream of the 5' limit of the current
cDNA sequence. This additional genomic sequence begins with an in-
frame stop codon and contains two in-frame ATGs (Fig. 3A). An
alternatively-spliced upstream exon isolated both from mouse testis
and HeLa cells (30) (EMBL Accession # X77486) was found to lie 800
bp downstream of exon 1 (Fig. 3B). These results show that tissue-
specific and alternative transcriptional start sites in mouse and
human tissues are localized upstream of the previously characterized
5' end of the gene (15).
A comparison of the new murine amino terminal cDNA
sequence with the published human cDNA (31) showed that these
sequences are highly conserved, especially at the beginning of the
ORF (Fig. 3A). Similar to the murine sequence, the human sequence
contains an ORF upstream of the published ATG initiation codon. In
the first shared 282 bp, the respective gene sequences are 85%
identical at the nucleotide level, and 91% identical at the amino acid
level. 33 / 41 nucleotide mismatches between the two sequences
result in silent mutations. This evolutionary conservation may
indicate an important and essential function of this amino-terminal
sequence, consistent with the data presented here.
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Expression of complete Dnmt cDNA in Dnmt mutant ES
cells restores normal genomic methylation levels. To test the
possibility that the newly-discovered cDNA sequence would allow
normal expression and MTase functioning in vivo, a mini-gene
expression construct was made and stably transfected into Dnmt
mutant ES cells. pMT50 was made by insertion of a 5.0-kb region of
the Dnmt locus that included the first exon into pMT30 (Fig. 4A).
pMT30 contained the previously reported Dnmt promoter (15) but
had been shown not to function in Dnmt mutant ES cells (Fig. lA).
pMT50 resulted in the Dnmt cDNA fused 3' to a 9.7-kb piece of
genomic Dnmt sequence that ended in the fourth exon and included
3.6 kb of genomic sequence upstream of the first exon, the two new
exons reported above, three introns, and the beginning of the fourth
exon.
Dnmts/s cells were electroporated with the linearized construct
and selected for puromycin resistance. Puromycin-resistant colonies
were expanded and analyzed by Southern blot for vector integration
and levels of genomic methylation. 7/12 clones examined showed
random integration into the genome (data not shown) and normal
levels of genomic methylation (Fig. 4B), as compared to wild type
cells. 2/12 clones had undergone an homologous targeting of the
construct to the endogenous Dnmt locus and the remaining 3 clones
had no transgene (data not shown). All clones carrying an intact
transgene displayed equivalent methylation profiles at repetitive
gene sequences and Xist. The imprinted genes H19 and Igf2r,
however, were not remethylated (data not shown), as reported
previously for a smaller, similar Dnmt cDNA-containing plasmid that
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was targeted to the endogenous Dnmt locus (16). Western blot
analysis revealed a range of MTase levels from 10-100% that of a
wild type allele, with the minigene-encoded enzyme co-migrating
with wild type MTase (Fig. 4C).
Three of the rescued lines were used to induce teratomas by
subcutaneous injection into syngeneic male host animals. While the
parental mutant cells failed to form palpable teratomas within 3-4
weeks (n = 0 / 12), the rescued ES cells induced teratoma formation
at a similar rate (n = 9 / 10) as the wild type Jl ES cells (n = 6 / 6).
Histological analysis of these teratomas revealed a wide variety of
differentiated cell types, consisting mostly of mature neural tissue
and including discrete patches of epithelial tissue, cartilage,
trophectoderm, osteoid, and a relative deficiency of striated muscle
(data not shown). From these results we conclude that the additional
sequences uncovered above are necessary for functional activity of
MTase in vivo.
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DISCUSSION
The experiments in this study were prompted by the failure of
published Dnmt cDNA clones to functionally complement the
hypomethylation phenotype of ES cells homozygous for various
mutations of the Dnmt gene.
regarding the structure and ft
Stably transfected ES cells
previously described Dnmt c
full-length cDNA led to wild
that the previously described
reading frame (ORF) of up to
was previously proposed to r
Genomic methylation levels
substantially as a result of t
Our results allow two main conclusions
inction of DNA methyltransferase. (i)
failed to express high levels of the
DNA clone, whereas expression of the
type expression levels. We conclude
cDNA is truncated, lacking an open
171 codons upstream of the ATG which
epresent the initiation codon (4). (ii)
in ES cells, which were decreased
he targeted inactivation of the Dnmt
gene, were restored to normal levels by expression of the Dnmt mini-
gene. This restoration of methylation was accompanied by functional
rescue of the transfected cells, as reflected in the ability to form
teratomas. Rescued cells behave identically to those reported
previously (16), in which the Dnmt cDNA was targeted to its cognate
locus. We conclude that the inclusion of the newly-identified
sequence is essential for stable expression and methyltransferase
activity in vivo.
Functional rescue of the Dnmt mutant phenotype suggests that
normal methylation patterns can by restored so as to assure
appropriate gene expression in differentiating ES cells. De novo
methylation of the demethylated genome is likely accomplished by
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an independently encoded DNA methyltransferase, as discussed
elsewhere (8, 16). Our results argue that demethylation of the
mutant ES cell genome does not result in irreversible alteration in
gene activity and / or chromatin structure. Rescue of the mutant
phenotype seems to be the result of a default de novo methylation
process which requires the expression of the hemi-methyltransferase
encoded by Dnmt, which would maintain methylation levels set by
the embryonic de novo methyltransferase.
Both the low expression levels in cells carrying the truncated
cDNA in stably transfected ES cells, and the restoration of high levels
of expression from constructs containing an in-frame stop codon in
the ORF, were consistent with a truncated polypeptide being
produced from the cDNA, translation of which may be detrimental to
ES cells. Indeed, we isolated additional upstream cDNA sequence
comprising two exons separated by an 11.5-kb intron. Examination
of the genomic sequence surrounding this new primary exon
revealed an uninterrupted open reading frame that begins upstream
of and continues throughout the two new exons, extending the
published coding sequence by 171 codons. Three new in-frame ATG
codons were found in this ORF. Lack of these extra sequences could
account for the size differences between MTase purified from cell
lines and the product expressed from the truncated Dnmt cDNA (12).
Comparison of the mobility in SDS-PAGE of wild type MTase with the
recombinant MTase produced from the expression constructs (Fig. 1D,
Fig. 4C) suggests the third ATG in the ORF most likely represents the
translational start site. Although the results do not determine which
of the three upstream ATGs is used as a translational start point in
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vivo, they do show that the new ORF is necessary for proper
functioning in vivo. Protein sequencing will resolve which ATG is
used as a translational start.
The first exon was found to lie within a CpG island, as defined
by Bird (32). Because of the GC-rich nature of the sequence, it is
difficult to ascertain whether the 5' end heterogeneity of the 12
examined clones reflects pausing by the reverse transcriptase or a
multiplicity of transcriptional start sites, as often observed in
housekeeping promoters associated with a CpG island. Our results
are not in agreement with the localization of the Dnmt promoter
localized upstream of exon 3, as reported by Rouleau et al. (15).
Expression from this promoter would produce a truncated MTase
which is detrimental to stably transfected cells, and Dnmt expression
constructs utilizing this promoter failed to effect complementation in
Dnmt mutant cells. Instead we suggest that a promoter contained
within the pMT50 construct represents the functionally relevant
transcriptional start site.
Several reports have demonstrated the ability to express high
levels of the truncated Dnmt cDNA in a transient fashion (12, 13). In
contrast, only a few reports have described high levels of MTase
expression in stably transfected clones of transformed cells (14, 33)
or in a myoblast cell line (34)8. This raises the question of whether
specific functional domains of the polypeptide may explain the low
Dnmt expression and the apparent toxicity of the truncated cDNA
when stably expressed in ES cells. It has been shown previously that
the truncated Dnmt cDNA, when expressed in COS cells, generates an
enzyme which methylates a hemimethylated DNA substrate with the
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same kinetics as MTase purified from MEL cells (12). Proteolytic
cleavage of the first 350 amino acids did not affect in vitro enzyme
activity (35). Consistent with these observations, expression of the
truncated Dnmt cDNA resulted in limited genomic remethylation in
Dnmts/s ES cells, raising the possibility that the detrimental effect of
truncated MTase in ES cells can be separated from its methylating
function. MTase is localized to nuclear DNA replication sites during
S-phase by an amino-terminal targeting domain (29). Because
insertion of stop codons within this targeting domain abolished the
toxic effect of truncated cDNA expression, we speculate that toxicity
may be mediated through this domain, possibly by targeting the
truncated MTase to replication sites and thereby stalling the
replication machinery. The isolation of a complete Dnmt cDNA allows
for analysis of these and many other biological questions, which can
finally be addressed through overexpression and tissue-specific
expression of the enzyme. The identification of a new transcriptional
start site also reopens the discussion on the regulation of Dnmt gene
expression, which is known to be complex.
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FIGURE LEGENDS
FIG. 1. Dnmt cDNA is inefficiently expressed in stable transfections
of ES cell lines. (A) Diagram of Dnmt expression constructs. The cDNA
used in all four constructs is the same. See Materials and Methods
for details of plasmid construction. (B) Northern blot analysis of
Dnmt expression in Dnmts/s lines transfected with pMT20 (lanes 4-
9). The wild type Dnmt transcript migrates at 5.2 kb and is indicated
by an arrow to the right of the blot. Expression levels are <1% of the
wild type allele in all clones shown, except for lanes 4 and 5, which
are 8 and 10 %, respectively. Wild type J1 (lane 1), Dnmts/+ (lane 2),
and Dnmts/s (lane 3) cells are shown for comparison. The Dnmt
cDNA was used as a probe. The lower figure shows the same blot re-
hybridized with an cx-tubulin cDNA (34) to control for amount of RNA
loaded. The bands migrating at 9.0 and 6.0 kb are created by the
disruption at the Sall site by a Pgk-Neo cassette, and hybridize with
a Neo probe (8). (C) Southern blot analysis of HpaII-digested
genomic DNA from Dnmts/s lines transfected with pMT20 (lanes 4-9,
same order as above). The Moloney Murine Leukemia Virus
(MoMuLV) cDNA (28) was used as a probe. Wild type J1 (lane 1),
Dnmtn/n (lane 2), and Dnmts/s (lane 3) cells are shown for
comparison. (D) Western blot analysis from Dnmts/s lines transfected
with pMT20, which show slight levels of genomic remethylation
(lanes 3 and 4 correspond to lanes 4, 5 in Fig. 1B/C). An amino-
terminal anti-MTase antibody was used in the left figure, and
Coomassie-stained gel shown as a loading control to the right. Wild
type J1 (lane 1), Dnmts/+ (lane 2), and Dnmts/s (lane 5) cells are
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shown for comparison. Biorad Silver Stain molecular weight markers
are shown to the side.
FIG. 2. Dnmt cDNA is efficiently expressed from carboxy-terminal
truncated constructs. The top figure shows pMT42, made by
inserting a stop-codon containing linker into the NsiI site in pMT40,
871 bp downstream of the initial ATG. Shown beneath is a Northern
blot analysis of Dnmt expression in Dnmts/s lines transfected with
pMT42. 4/8 of the examined transfectants (lanes 5-12) showed an
expression level approximately 50% that of the wild type cells. The
following lines are shown for comparison: wild type Ji (lane 1),
Dnmts/+ (lane 2), Dnmts/s (lane 3), and D23 (lane 4), a pMT40-
transfected Dnmts/s cell line showing slight levels of Dnmt cDNA
expression and genomic remethylation. The Dnmt cDNA was used as
a probe. The lower figure represents the same blot re-hybridized
with an oc-tubulin cDNA to control for amount of RNA loaded. S
allele-specific bands are as described in Fig. IB.
FIG. 3. The complete Dnmt cDNA contains two additional 5' exons
which extend the open reading frame by up to 171 codons. (A)
Comparison between murine and human Dnmt sequences at the 5'
end. New sequence reported in this paper is shown in uppercase
letters, with previously reported sequence in lowercase. The first
two rows of sequence are genomic sequence, while the seven rows
beneath represent cDNA sequence. A previously reported human
cDNA (31) is shown beneath the murine sequence with all matches
represented by a vertical bar. A predicted translation of the 182-
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codon extension of the ORF is shown above the murine nucleotide
sequence, starting with the stop codon TAG and with the four
methionine residues boxed. Differences in the human amino-acid
sequence are represented beneath the human nucleotide sequence.
Vertical bars running through the murine sequence denote exon-
exon boundaries, with the numbers corresponding to the exon
designations used in Fig. 3B. The two boxed sequences represent the
primers MMT2214AS (1) and MMT2363AS (2) used in the cloning
experiments. The EcoRI site that marks the beginning of the Dnmt
cDNA used in the expression constructs in Fig. 1 is indicated by a bar
over the recognition sequence. The major transcriptional start site
found by Rouleau et al. (15) is indicated by a vertical arrow. (B) Map
of exonic structure of the 5' end of Dnmt. The first four exons of
Dnmt are represented to scale with respect to their size and relative
position in the gene. Exon numbers described in text are given
above. The splicing of the first four exons of Dnmt is diagrammed
above, while the alternative splicing observed in mouse testis (30) is
shown beneath. The numbering of the nucleotide scale starts with 0
as the 5' end of the new cDNA sequence. The two alternative exons
are separated from the second, common exon by a 10-kb interval of
genomic DNA, indicated by the broken lines in the splicing diagram.
CpG and GpC incidence diagrams are plotted beneath, to scale with
the rest of the diagram. The two 3'-proximal ATGs indicated by a
boxed M in Fig. 3A are shown here in their genomic locations, while
the first two ATGs are indicated by vertical arrows to the left of Exon
1. The major transcriptional start site found by Rouleau et al. (15) is
indicated by a horizontal arrow beneath Exon 3.
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FIG. 4. Restoration of normal genomic DNA methylation levels upon
expression of the full-length Dnmt cDNA. (A) Map of pMT50, showing
its relation to Dnmt genomic sequence and the exons therein (drawn
to scale). The first three exons of Dnmt are represented by
numbered boxes and correspond to those shown in Fig. 3B. The
vertical arrow represents the transcriptional start site reported in
Rouleau et al. (15). EcoRI (E) and NaeI (N) sites used in cloning are
indicated. The Dnmt cDNA and Pgk-i polyadenylation signal (P) are
both represented by boxes. The amount of Dnmt genomic sequence
used in pMT30 is shown beneath by the arrow. (B) Southern blot
analysis of HpallI-digested genomic DNA, probed with the MoMuLV
cDNA. Wild type J1 (lane 1,) and Dnmts/s cells (lane 2) are shown,
followed by pMT50-transfected Dnmts/s cells (lanes 3, 4). (C)
Western blot analysis of the pMT50-transfected cells shown in Fig.
4B (lanes 4, 5). An amino-terminal anti-MTase antibody was used in
the left figure, and Coomassie-stained gel shown as a loading control
to the right. Wild type J1 (lane 1, 6), Dnmts/+ (lane 2), and Dnmts/s
(lane 3) cells are shown for comparison. Biorad Silver Stain
molecular weight markers are shown to the side.
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ABSTRACT
Embryonic stem (ES) cells homozygous for a disruption of the DNA
(cytosine-5)-methyltransferase gene (Dnmt) proliferate normally
with their DNA highly demethylated but die upon differentiation.
Expression of the wild type Dnmt cDNA in mutant male ES cells
caused an increase in methylation levels of bulk DNA and of the Xist
and Igf2 genes to normal levels, but did not restore the methylation
of the imprinted genes H19 and Igf2r. These cells differentiated
normally in vitro and contributed substantially to adult chimeras.
While the Xist gene was not expressed in the remethylated male ES
cells, no restoration of the normal expression profile was seen for
H19, Igf2r, or Igf2. This indicates that ES cells can faithfully
reestablish normal methylation and expression patterns of non-
imprinted genes but lack the ability to restore those of imprinted
genes. Full restoration of monoallelic methylation and expression
was imposed on H19, Igf2 and Igf2r upon germline transmission.
These results are consistent with the presence of distinct de novo
DNA methyltransferase activities during oogenesis and
spermatogenesis which specifically recognize imprinted genes but
which are absent in the post-implantation embryo and in ES cells.
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INTRODUCTION
Much evidence indicates that in vertebrates the methylation of
DNA at cytosine residues correlates with gene inactivity (Yeivin and
Razin, 1993). Methylation patterns are generally stably maintained
in somatic cells of the animal but change dramatically during early
development when the genome of the mammalian embryo undergoes
consecutive waves of demethylation and de novo methylation (Razin
and Shemer, 1995). The methylation present in the DNA of the
zygote is erased during cleavage so that the genome of the blastocyst
is almost completely unmethylated (Monk et al., 1987; Kafri et al.,
1992). After implantation, the embryo undergoes a wave of global
de novo methylation which restores the genomic methylation levels
of the gastrulating embryo to that seen in the adult (Jihner et al.,
1982; Monk et al., 1987). During gametogenesis, the unmethylated
DNA of the primordial germ cells becomes de novo methylated (Kafri
et al., 1992; Monk et al., 1987), a process which ultimately leads to
the high methylation levels of the zygote. De novo methylation of
transduced retroviral genomes is also seen in pregastrulation
embryos (Jihner et al., 1982) and in embryonic carcinoma (EC) and
stem (ES) cells (Stewart et al., 1982; Lei et al., in preparation),
consistent with the hypothesis that a de novo DNA methyltransferase
activity is expressed in early stages of development.
The crucial importance of DNA methylation in development was
demonstrated by the targeted mutation of the single known
mammalian DNA methyltransferase gene (Dnmt) in embryonic stem
cells (Li et al., 1992). Dnmt is believed to encode a maintenance
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methyltransferase, because in vitro the enzyme (MTase) shows a
substrate preference for hemimethylated DNA (Bestor and Ingram,
1983; Gruenbaum et al., 1982). Three mutant alleles of the Dnmt
gene have been generated (Lei et al., in preparation; Li et al., 1993; Li
et al., 1992). A partially inactivated allele (Dnmtn) causes lethality
of homozygous mutant embryos at the 25 somite stage, whereas
embryos homozygous for completely inactivated alleles (Dnmts and
Dnmtc) die at the 5 somite stage. ES cells homozygous for any of the
alleles proliferate normally with their genomic DNA highly
demethylated but die upon induction of differentiation. ES cells
homozygous for any disruption, however, retain the ability to de
novo methylate transduced DNA, supporting the notion of an
independently-encoded de novo DNA methyltransferase being
expressed in embryonic cells (Lei et al., in preparation).
Imprinted genes display parent-specific monoallelic expression
(Barlow, 1995; Surani, 1994), although often not at all developmental
stages (Szabo and Mann, 1995). Genes which are predominantly
expressed from the maternal allele include Igf2r (Barlow et al.,
1991), H19 (Bartolomei et al., 1991), Mash2 (Guillemot et al., 1995)
and p57KIP2 (Hatada and Mukai, 1995), while Igf2 (DeChiara et al.,
1991), Mas (Villar and Pedersen, 1994), Snrpn (Leff et al., 1992),
U2afbp-rs (Hayashizaki et al., 1994), insl/ins2 (Giddings et al.,
1994), IPW (Wevrick et al., 1994), and Pegl/Mest (Kaneko-Ishino et
al., 1995) are expressed paternally. DNA methylation has been
proposed to constitute the molecular mark which distinguishes the
two alleles of imprinted genes. Evidence for DNA methylation
constituting the imprinting mark includes differential methylation of
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imprinted transgenes (Chaillet et al., 1991; Reik et al., 1987; Sapienza
et al., 1987; Swain et al., 1987) and imprinted endogenous genes.
The acquisition and developmental propagation of the methylation
mark has been described in detail for the two imprinted genes H19
and Igf2r, and for Xist, a gene encoded at the center for X
chromosome inactivation which shows imprinted expression only in
preimplantation embryos and extraembryonic tissues (Kay et al.,
1993). The H19 gene acquires paternal-specific methylation in a
region upstream of its promoter during spermatogenesis (Tremblay
et al., 1995), while Igf2r (Stiger et al., 1993) and Xist (Ariel et al.,
1995; Zuccotti and Monk, 1995) acquire a maternal-specific
methylation mark during oogenesis. Importantly, the allele-specific
methylation differences in these "imprinting boxes" are resistant to
the wave of global demethylation during cleavage and the
subsequent wave of global de novo methylation before gastrulation
(Bartolomei et al., 1993; Brandeis et al., 1993; St6ger et al., 1993;
Tremblay et al., 1995). This assures that the methylation mark
imposed on the two alleles of imprinted genes during gametogenesis
remains unaltered during development and, therefore, distinguishes
the two alleles in each cell of the organism. In contrast to HI9 and
Igf2r, the methylation imprint of the maternal Xist allele is erased
after implantation in cells of the embryonic lineage, and either the
paternal or the maternal allele becomes methylated at the time of X
inactivation (Norris et al., 1994).
Strong evidence for methylation being crucial for the maintenance
of monoallelic expression of imprinted genes was provided by the
analysis of Dnmt mutant embryos (Li et al., 1993; Beard et al., 1995).
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Hypomethylation of the DNA in mutant embryos or ES cells resulted
in loss of monoallelic expression, either in the activation of the
inactive H19 and Xist alleles or in the inactivation of the active Igf2r
and Igf2 alleles. These experiments did not, however, provide
insights into the role of methylation in the establishment of genomic
imprinting during gametogenesis.
In this paper we address the process by which the allele-specific
methylation of imprinted genes is acquired. We have expressed the
wild type Dnmt cDNA in homozygous Dnmt mutant ES cells to assess
whether this would restore the low methylation levels of the
genomic DNA to normal. While normal methylation levels of non-
imprinted DNA were reestablished, imprinted genes were neither
remethylated nor appropriately expressed. However, passage of the
remethylated ES cells through the germ line restored normal
methylation and expression to all imprinted genes analyzed.
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RESULTS
Expression of functional MTase in Dnmt mutant ES cells
leads to restoration of genomic methylation
Previous work had demonstrated that the DNA of homozygous
mutant Dnmt ES cells was highly hypomethylated (Lei et al., in
preparation; Li et al., 1992). To assess whether expression of the wild
type MTase would restore genomic methylation levels and rescue the
lethal phenotype of differentiated mutant cells, we introduced the
Dnmt cDNA into mutant ES and embryonic germ (EG) cells. The two
cell types displayed identical molecular characteristics and functional
capacity before and after expression of the Dnmt cDNA. For the sake
of simplicity, they are collectively referred to as ES cells in the text.
To assure correct quantitative and developmental expression of the
construct, the cDNA was inserted by homologous recombination into
the cognate Dnmt locus upstream of the mutation, using a strategy we
refer to as CHIP (cDNA homologous insertion protocol; see Materials
and Methods). The vector (Figure lA), fused the Dnmt cDNA 3' to a
4.8-kb piece of genomic Dnmt sequence which ended in the second
known exon (Rouleau et al., 1992). Homologous insertion of this
hybrid vector was expected to leave all upstream control elements of
the gene intact, leading to restoration of normally-regulated MTase
expression. Dnmt mutant cells were electroporated with the
linearized construct and selected for puromycin resistance. All
puromycin-resistant colonies were expanded and analyzed by
Southern blot for vector integration and levels of genomic
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methylation. Genomic DNA was digested with Scal and Southern blots
hybridized with probe HV. This yields a 17.5-kb fragment in wild-
type Ji and Dnmt mutant cell lines (Fig. IB, Lanes 1, 2), but a 22-kb
and a 7.4-kb fragment for the targeted allele of an homologous
integrant (Lanes 3, 4). By this analysis, 73 / 182 puromycin-resistant
clones had undergone homologous recombination events in which a
single copy of the plasmid integrated at a single allele (data not
shown). Northern blot analysis was used to assess the level of Dnmt
transcription. The size of the endogenous mRNA is 5.2 kb (Fig. IC,
Lane 1). Virtually no mRNA of this size is observed in homozygous
mutant Dnmt cells (Lane 3). Puromycin-resistant cells which
underwent homologous recombination (Lanes 4, 5) show that the
inserted cDNA was transcribed at a level and size comparable to that
of the endogenous allele (lane 2).
All 73 homologous recombinants examined showed near-complete
genomic remethylation (Fig. 2), as assayed using two repetitive
sequence probes: a Moloney Murine Leukemia Virus (MoMuLV)
cDNA, which cross-hybridizes with endogenous C-type retroviruses
scattered throughout the genome (Stuhlmann et al., 1981), and a
minor satellite centromeric repeat (Chapman et al., 1984). Both of
these repeated sequences are heavily methylated in J1 cells (Fig. 2,
Lane 1), as seen by Southern blot analysis of genomic DNA digested
with Hp a II, an enzyme sensitive to the methylation of internal
cytosines in its CCGG recognition sequence. DNA methylation in Dnmt
mutant cells was highly reduced (Lanes 2), as seen by the increasing
intensity of lower molecular weight bands in Dnmt mutant cell lines.
The methylation level of both sequences was restored to normal in all
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clones with a homologously integrated construct (Lanes 3, 4). No
puromycin-resistant clones in which pMWT-PURO had integrated
non-homologously displayed either Dnmt expression or genomic
remethylation (data not shown). We conclude that remethylation of
bulk DNA in the genome of homozygous mutant Dnmt cells is
achieved by expression of the Dnmt cDNA from its endogenous
promoter. Dnmt mutant cells which express the cDNA shall
henceforth be referred to as "rescued" cells.
MTase expression complements lethal phenotype of
differentiating mutant Dnmt ES cells
Previous observations indicated that homozygous mutant Dnmt ES
cells, while proliferating normally when undifferentiated, die upon
induction of differentiation (Beard et al., 1995; Lei et al., in
preparation) and do not contribute to adult chimeras after injection
into wild-type blastocysts (see below). We were interested to test
whether restoration of genomic DNA methylation levels in mutant ES
cells carrying the Dnmt cDNA would rescue the lethal mutant
phenotype. To test in vitro differentiation, the rescued cells were
induced to differentiate by plating on bacteriological petri dishes, in
the absence of a fibroblast feeder layer and LIF. In contrast to the
parental mutant cells (Lei et al., in preparation), the rescued cells
differentiated and proliferated normally (data not shown). This
indicates that in vitro differentiation potential was restored by
genomic remethylation.
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To more stringently test the developmental potential of the
remethylated cells, in vivo experiments were conducted. First, the
cells were injected subcutaneously into syngeneic male host animals.
While the parental mutant cells failed to form palpable teratomas
within 3-4 weeks (n = 0 / 24), the rescued ES cells induced teratoma
formation at a similar rate (n = 21 / 24) as the wild-type J1 ES cells
(n = 11 / 12). Second, the rescued cells were injected into wild-type
BALB/c blastocysts to test their ability to contribute to chimeras. The
parental Dnmt mutant cells were completely incapable of contributing
to adult chimeras (n = 0 of 64 injected blastocysts). When rescued
cells were used instead, eleven chimeras were generated with
donation to coat color ranging from 10 to 70% (n = 11 of 92 injected
blastocysts). The animals appeared normal in size and appearance,
and contribution to the germline was observed in three chimeras
derived from two rescued cell lines (see below).
The results described so far show, therefore, that expression of
functional MTase in Dnmt mutant ES cells restores normal
methylation levels and results in the rescue of the lethal mutant
phenotype.
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Methylation and monoallelic expression of imprinted genes
is not restored in rescued ES cells
The methylation levels and expression of the imprinted genes
H19, Igf2r, Igf2, and Xist were assessed by Southern blot and by
RNase protection analysis. The analyses were performed on
undifferentiated and in vitro differentiated ES cells. To investigate
methylation and expression in terminally differentiated cells,
fibroblasts were isolated from the chimeras described above.
Primary fibroblast cultures were prepared from the carcasses of four
chimeras. The primary cultures were immortalized with SV40 virus
and then selected with puromycin to enrich for cells derived from the
injected EG cells. Puromycin-selected populations were then
subcloned at limiting dilution to prevent contamination from wild-
type fibroblasts.
Methylation of H19: In normal ES cells and mice a 3.8-kb region
just upstream of the promoter displays a monoallelic methylation
pattern (Bartolomei et al., 1993), in which the paternally-derived
allele is completely methylated (migrating at 3.8 kb, Fig. 3A, lanes 2,
3), while the maternally-derived allele is hypomethylated at the HhaI
sites within the region (lower molecular weight bands, lanes 2, 3).
Within this region lie three CpG sites that become methylated in
spermatogenesis and remain methylated exclusively on the
paternally-derived allele throughout development (Tremblay et al.,
1995). This region becomes completely demethylated in Dnmt
mutant ES cells (lanes 4, 5), indicating a complete loss of methylation
at both alleles. In the rescued ES cells (lanes 6, 8) these sites
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remained hypomethylated at both alleles, and in vitro differentiation
did not result in remethylation of this region (lanes 7, 9). To see if
remethylation of this region occurred in terminally differentiated cell
types in vivo, immortalized fibroblasts prepared from chimeras were
examined. Puromycin-selected populations (lanes 11, 12), which
were derived from the rescued ES cells, displayed no evidence of
remethylation at either allele of H19 [compare to fibroblasts derived
from a wild-type mouse (lane 10), which display a fully-methylated
allele (migrating at 3.8 kb) and a demethylated allele (lower
molecular weight bands)].
Methylation of Igf2r: The methylation of the Igf2r gene was
similarly determined. It has been shown that an intronic CpG-rich
region (Stager et al., 1993) displays a monoallelic methylation pattern
in which the maternally-derived allele is completely methylated
(migrating at 2.9 kb, Fig. 3B, lane 2), while the paternally-derived
allele is hypomethylated at the HpaII sites within the region (lower
molecular weight bands, lane 2). Both alleles were completely
demethylated in Dnmt mutant ES cells (lane 3), indicating a complete
loss of methylation at both alleles. In the rescued ES cells (lanes 4, 5)
these sites remained hypomethylated at both alleles. Neither in vitro
differentiation of these cells nor twenty serial passages resulted in
remethylation of this region (data not shown). The methylation
pattern seen in puromycin-selected fibroblasts (lanes 7, 8) was
similar to that seen in rescued ES cells [compare fibroblasts derived
from a wild-type mouse (lane 6), which display a monoallelic
methylation pattern, with rescued fibroblasts, which are
hypomethylated at both alleles].
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Methylation of Igf2: Unlike H19 and Igf2r, Igf2 does not possess a
region which becomes differentially methylated in the gametes
(Brandeis et al., 1993). However, in adult mice a 1.5-kb region
upstream of the first Igf2 promoter has been shown to display a
differential methylation pattern (Brandeis et al., 1993; Feil et al.,
1994; Sasaki et al., 1992). In contrast to H19 and Igf2r, this region
does not display absolute methylation differences, but the paternally-
derived allele is on average more methylated. As reported before
(Feil et al., 1994), examination of HpaII-digested genomic DNA from
wild-type ES cells revealed a pattern similar to that seen in
embryonic and adult tissues, with a fully-methylated band (migrating
at 1.5 kb, Fig. 3C, lane 2) and a ladder of fragments representing
progressive demethylation, moving 3' to 5', of four 3'-proximal HpaII
sites (lower molecular weight bands, lane 2). This region became
mostly demethylated in Dnmt mutant ES cells (lane 4), indicating a
near-complete loss of methylation at both alleles. In the rescued ES
cells (lanes 6, 8), a methylation pattern very similar to wild-type ES
cells was established, though the fraction of demethylated 3'-
proximal HpaII sites remained higher than in wild-type cells. It is
likely that this pattern reflected biallelic methylation. Upon in vitro
differentiation, Igf2 became slightly demethylated (lanes 7, 9),
whereas puromycin-selected fibroblasts (lanes 11, 12) revealed a
state of hypomethylation almost as extensive as that seen in Dnmt
mutant ES cells (lanes 4, 5 ), in striking contrast to the pattern seen in
wild-type fibroblasts (lane 10).
Expression of H19 , Igf2r, and Igf2: Expression was analyzed by
RNase protection assay in wild type, Dnmt mutant and rescued ES
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cells before and after induction of differentiation. All
undifferentiated cells showed the same level of Igf2r expression and
little or no expression of HI9 and Igf2 (lanes 1, 3, and 5, in Fig. 4B, A,
and D). Upon differentiation, however, the expression of Igf2
increased significantly in wild-type ES cells (Fig. 4D, lane 2) with little
or no increase seen in the mutant (lane 4) or rescued ES cells (lane 6).
Although Igf2r expression appeared to increase only slightly upon
differentiation of wild-type ES cells (Fig. 4B, lane 2), it showed a
noticeable decrease in expression in the differentiated mutant (lane
4) and rescued ES cells (lane 6). Like Igf2, H19 expression increased
significantly in wild-type ES cells (Fig. 4A, lane 2) upon
differentiation, and further increased by at least a factor of two in
mutant (lane 4) and rescued ES cells (lane 6). In Dnmt mutant
embryos, an increase in H1 9 expression relative to wild-type
embryos has been shown to be caused by biallelic expression of the
gene (Li et al., 1993). The ES cell lines used for these studies were
not marked by any polymorphism to distinguish the alleles of H19,
but the overexpression seen in rescued ES cells is consistent with a
biallelic transcriptional profile.
To determine if expression of these imprinted genes returned to
wild-type levels in terminally differentiated cells in vivo, RNA was
prepared from wild-type and rescued mutant fibroblasts derived
from a P7 (PO = day of birth) mouse. Igf2r expression, which was
found at high levels in the wild-type fibroblasts (Fig. 4C, lanes 1, 2),
was found to be completely extinguished in the rescued mutant
fibroblasts (lanes 3-6). No significant expression of H19 and Igf2 was
seen in either wild-type or rescued mutant fibroblast clones (data not
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shown). The lack of expression of Igf2 and H19 in wild-type cells was
probably caused by a developmental down-regulation of these genes,
for the following reasons: 1) expression of Igf2 was observed in wild-
type fibroblast cultures derived from a 16.5 day-old embryo (data
not shown), and 2) H19 is known to be switched off in most tissues
soon after birth (Poirier et al., 1991).
Xist: This gene, in contrast to the imprinted genes described above,
is imprinted only in extraembryonic tissues. The maternal allele is
methylated and the paternal allele remains unmethylated throughout
cleavage and in the extraembryonic lineage (Ariel et al., 1995;
Zuccotti and Monk, 1995). Following implantation, however, the
maternal imprint is erased and one of two alleles becomes randomly
methylated and silent at the time of X chromosome inactivation
(Norris et al., 1994). Xist becomes differentially methylated in a 1.5-
kb region surrounding its promoter (Norris et al., 1994), with two
clusters of CpG sites showing gamete-specific methylation, one cluster
just upstream of the transcriptional start site (Zuccotti and Monk,
1995) and the other 600 bp downstream (Ariel et al., 1995). In male
ES cells, with a single, maternally-derived X-chromosome, this region
is almost completely methylated (Fig. 3D, lane 2). In Dnmt mutant ES
cells, this methylation is completely erased (lane 4), including the
gamete-specific methylation sites. The same degree of partial
methylation seen in wild-type ES cells was observed in the rescued ES
cells (lanes 6, 8). As shown before (Beard et al., 1995), in vitro
differentiation of wild-type J1 cells results in an increase in
methylation (lane 3), and this is also seen for the rescued ES cells
(lanes 7, 9). Also as shown previously (Beard et al., 1995), this
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demethylation results in the expression of Xist upon differentiation,
of Dnmt mutant ES cells (Fig. 4E, lane 4) but not Jl (lane 2) or rescued
ES cells (lane 6).
Our results show that methylation and expression of the imprinted
genes H19 and Igf2r were not restored to normal levels following
expression of MTase in homozygous Dnmt mutant ES cells or their
differentiated derivatives, in contrast to repetitive DNA sequences
and Xist. These observations suggest, therefore, that once the
genomic DNA has been demethylated by deletion of the maintenance
MTase, the de novo methylation activity in ES cells can distinguish
between two classes of genes: (i) the majority of genes, as evidenced
by the repetitive probes in Figure 2 or Xist, which can be
remethylated to normal levels so as to assure normal expression
patterns during subsequent differentiation; (ii) imprinted genes such
as H19 and Igf2r, which cannot be remethylated and functionally
restored once demethylated.
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Normal methylation and expression patterns of imprinted
genes are restored after passage through the germline
To test whether germline transmission would restore normal
methylation and expression patterns to imprinted genes, five male
chimeras, generated from a rescued ES cell line, were mated to
BALB/c females. Three of these chimeras, derived from two
independently-transfected ES cell lines, produced agouti offspring,
indicating contribution of the rescued genome to the germline. The
Dnmt allele which had undergone homologous recombination was
transmitted at the expected frequency, and pups carrying the D nmt
cDNA appeared identical to their littermates. Paternal transmission of
the imprinted genes contributed by the rescued ES cells makes clear
predictions regarding the methylation and expression status of
imprinted genes in the offspring. For example, after germline
transmission the paternal H19 allele should be methylated and the
paternal Igf2 allele should be expressed. H19 methylation in tail
preparations was examined as described above. The same
methylation pattern was seen in pups derived from the rescued ES
cells (Fig. 5D, lanes 2-4) as in pups derived from the host-blastocyst
(lane 1). As the examined promoter-proximal region of H19 is known
to be unmethylated on the maternally-derived allele (Tremblay et al.,
1995), we conclude that methylation of the paternally-derived allele
had occurred in germline transmission. Methylation of Igf2r and Igf2
was examined in the same regions described above. A wild-type
methylation pattern was seen for Igf2r (Fig. 5F), which is consistent
with the paternally-derived allele of this gene remaining
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hypomethylated after germline passage. Finally, a wild-type
methylation pattern was observed for Igf2 (Fig. 5E), indicating full
methylation of the paternally-derived allele.
RNase protection analysis was performed on total RNA prepared
from PO pups. Identical levels of Igf2 RNA were observed in pups
derived from the rescued ES cells (Fig. 5B, lane 1) as in pups derived
from the host-blastocyst (lane 2). Since Igf2 is not expressed from
the maternally-derived allele (DeChiara et al., 1991), we conclude that
this expression was derived from the paternally-transmitted allele.
Similar results were observed for expression levels of H19 (Fig. 5A)
and Igf2r (Fig. 5C).
These results indicate that normal methylation patterns were
restored to both alleles of H19 in the male gonad, resulting in the
appropriate expression of both H19 and Igf2 from the paternally-
derived alleles in the germline pups (see Discussion). The presence of
an unmethylated Igf2r allele in these pups, and wild-type levels of
Igf2r expression in germline-transmitted embryos, indicates that this
gene was not remethylated in the male gonad. By extension,
methylation of both alleles of Igf2r would presumably occur upon
germline transmission through a female chimera, but none of the four
female chimeras produced agouti offspring. In conclusion, our results
suggest that de novo methylation of the imprinted genes H19 and
Igf2r, in contrast to "bulk" DNA and the Xist and Igf2 genes, can only
occur after passage through the germ line.
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DISCUSSION
The experiments in this study were designed to examine the
developmental specificity of DNA methylation activity in the mouse.
Because gross genomic hypomethylation is tolerated by Dnmt
mutant ES cells, we could start at a specific point in the murine life
cycle with a near-complete deficiency of genomic methylation and
determine the sites and times of methylation activity. Our results
allow the two following conclusions regarding the function of the
DNA methyltransferase: (i) Genomic methylation levels in ES cells,
which were decreased substantially as a result of the targeted
inactivation of the Dnmt gene, could be restored to normal by
expression of a functional Dnmt gene. That this remethylation
process has restored normal methylation patterns to the genome is
inferred by the ability of these remethylated cells to undergo normal
differentiation in vitro, to form teratomas, and contribute extensively
to chimeras in vivo. In contrast, the parental mutant cells fail to
differentiate normally in each of these assays. (ii) Upon Dnmt cDNA
expression in ES cells, the imprinted genes H19 and Igf2r were not
remethylated at either allele, and as a consequence were not
appropriately expressed. Despite this deficiency, the cells were able
to contribute substantially to chimeras, including the gonad.
Importantly, normal methylation patterns and expression of the two
imprinted genes Igf2 and H19 were restored after passage through
the male germline.
Expression of functional MTase in the fully hypomethylated Dnmt
mutant ES cells complemented the mutant phenotype, leading to a
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substantial restoration of normal genomic DNA methylation levels, as
assayed by various repetitive sequence probes. In vitro, the enzyme
prefers hemimethylated over unmethylated substrates (Gruenbaum
et al., 1982), consistent with the notion that the Dnmt gene encodes
the maintenance methyltransferase which is expressed in every cell.
How might re-expression of a maintenance methyltransferase
activity result in de novo methylation of the unmethylated genomic
DNA in mutant ES cells? We have postulated previously that early
embryos as well as undifferentiated ES cells express a de novo DNA
methyltransferase that is not active in postgastrulation embryos
(Jihner et al., 1982) or in differentiated ES cells (Stewart et al.,
1982). The low but stable level of genomic DNA methylation in Dnmt
mutant ES cells is likely caused by the activity of a separately-
encoded enzyme (Lei et al., in preparation), which is insufficient to
maintain normal methylation levels in the absence of the
maintenance DNA methyltransferase. Re-expression of the
maintenance methyltransferase would, however, be expected to lead
to an increase in methylation levels as it would maintain the
methylation levels set by the embryonic de novo methyltransferase
activity.
Dnmt mutant ES cells, while proliferating normally when
undifferentiated, grow poorly and die upon induction of
differentiation, with the level of genomic DNA methylation
decreasing (Lei et al., in preparation). This is consistent with the
embryonic de novo DNA methyltransferase becoming inactive upon
differentiation, leading to further hypomethylation. An important
issue was whether re-expression of MTase not only would restore
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genome-wide methylation levels but also lead to rescue of the
mutant phenotype, which is a reduction in differentiation capacity in
vitro and in vivo (Lei et al., in preparation; Li et al., 1992).
Remethylated cells have clearly regained the ability to differentiate,
as evidenced by three different assays: in vitro differentiation as
embryoid bodies, teratoma formation, and contribution to the tissues
of chimeras, which represents the most stringent functional test. The
extensive coat color contribution to these normal chimeras suggests
that single-copy genes had become appropriately remethylated and
were correctly expressed, resulting in normal embryonic
development. The restoration of wild-type methylation levels and
consequent transcriptional inactivation was observed for the single-
copy gene Xist. Xist is not imprinted in male ES cells and embryonic
derivatives because the single copy of this gene is normally
methylated and unexpressed (Norris et al., 1994). The partially
methylated pattern seen in normal male ES cells (Beard et al., 1995)
was restored to the same degree in the rescued ES cells.
Importantly, the CpG sites showing gamete-specific methylation
(Ariel et al., 1995; Zuccotti and Monk, 1995) were remethylated,
supporting the notion that methylation of these sites leads to
transcriptional inactivity of Xist. The remethylation of Xist, coupled
with the functional complementation assays, suggests that the
methylation of all or most other non-imprinted genes is fully
restored. It is possible, however, that some genes, whose
misexpression would not compromise normal development, are not
becoming appropriately remethylated. A detailed study of
remethylation at individual loci will address this issue and yield
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information regarding the functional importance of methylation at
specific sites as compared to overall methylation patterns.
The imprinted genes H19 and Igf2r were not remethylated after
introduction of the Dnmt cDNA into the mutant ES cells. The regions
examined for methylation show a gamete-specific methylation
difference and are believed to constitute the primary imprinting
mark (Barlow, 1995). The methylation of these regions and
expression status of these genes in rescued ES cells was identical to
that seen previously in Dnmt mutant ES cells and embryos (Li et al.,
1993). Furthermore, hypomethylation persisted in ES cell-derived
fibroblasts isolated from chimeras, and methylation was restored to
normal only after germline transmission. In contrast to H19 and
Igf2r, Igf2 was extensively remethylated in an area which has been
shown to be differentially methylated in the adult (Brandeis et al.,
1993; Feil et al., 1994; Sasaki et al., 1992), but not in the gametes
(Brandeis et al., 1993). Why methylation levels of Igf2 decreased in
fibroblasts derived from rescued ES cells is not clear at this time. It
has been suggested that Igf2 expression depends upon the
availability of two enhancers shared with the closely-linked H19
gene, Igf2 being expressed only when the promoter of H19 is
methylated and inaccessible to its downstream enhancers
(Bartolomei et al., 1993). In mice lacking the H19 gene, a
maternally-transmitted deletion results in both the methylation and
the transcription of Igf2 (Leighton et al., 1995a), while in mice
lacking the downstream enhancers, a paternally-transmitted deletion
results in an abrogation of Igf2 transcription from that allele
(Leighton et al., 1995b). In our study, methylation was restored to
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Igf2, but little expression of the gene was seen in differentiated ES
cells, similar to the Dnmt mutant ES cells and embryos. Our results
support the idea that the methylation and expression status of H19 is
the primary determinant of Igf2 expression, and that methylation of
Igf2 in the examined region does not affect its expression.
Our observations are of general significance in defining the stage
in development for, and the mechanisms involved in, the
establishment of genomic imprinting. Figure 6 contrasts the
developmental changes in methylation of bulk DNA and Xist with
that of the imprinted genes H19 and Igf2r. While it is generally
assumed that imprinted genes acquire their methylation mark
during gametogenesis, no direct evidence of an enzyme activity
involved in gamete-specific methylation has been demonstrated. Our
results show conclusively that passage through the male germ line is
necessary to obtain the allele-specific methylation mark on at least
one imprinted gene, H19. This suggests the existence of a male-
specific de novo methyltransferase activity which may specifically
recognize all paternally-modified imprinted genes. Presumably a
female-specific de novo methyltransferase activity exists, which
would be active during oogenesis and would be expected to recognize
maternally-imprinted genes such as Igf2r. While other results
strongly suggest that the de novo methyltransferase expressed in ES
cells is an independently-encoded enzyme (Lei et al., in preparation),
we have no evidence whether the gamete-specific activities are
encoded by separate genes, are due to modification of the
maintenance MTase or the separately-encoded de novo
methyltransferase activity (Lei et al., in preparation), or are
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reflective of a change in chromatin structure affecting substrate
accessibility.
It is of interest to compare the rescued mutant ES cells with cells
derived from androgenetic (AG) or parthenogenetic (PG) embryos
(Fundele and Surani, 1994). Chimeras between wild type embryos
and either PG- or AG-derived embryonic cells are generally inviable
and show highly skewed and complementary distribution of the
uniparental cells to different tissues of the chimera (Fundele et al.,
1989; Fundele et al., 1990; Mann et al., 1990; Nagy et al., 1989;
Thomson and Solter, 1988). The phenotype of the chimeras has been
proposed to be caused by unbalanced expression of the imprinted
genes in the uniparental component (Allen et al., 1994; Szabo and
Mann, 1994). In contrast to PG- or AG-derived embryonic cells, the
rescued ES cells described here have methylation erased at both
paternally- and maternally-methylated loci, and the subsequent
biallelic expression patterns of these genes resulted in a qualitatively
different transcriptional profile. Chimeras produced from the
rescued ES cells had extensive coat color contribution and were
normal. Analysis of organ-specific contribution in chimeras and the
possibility of producing embryos derived exclusively from the
rescued ES cells (Nagy et al., 1990) will allow us to fully assess the
developmental potential of a mouse lacking an imprinted genome.
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MATERIALS AND METHODS
Tissue Culture
The wild-type J1 (Li et al., 1992), Dnmt n/ n clone 10, (Li et al., 1992),
Dnmts/s, and Dnmtc/c (Lei et al., in preparation; Li et al., 1993) ES cell
lines were used. ES cell lines were cultured as described by Li et al.
(1992). ES cells were induced to differentiate into embryoid bodies
by suspension culture in bacteriological petri dishes, as described
(Robertson, 1987), and were collected at day 15 for analysis. A
Dnmts/s EG cell line was derived from a cross between Dnmts/+ mice.
Primordial germ cells were cultured from gestational day 8.5
embryos on SI 4 -m220 feeder cells with 1000 U/ml LIF and 20 ng/ml
bFGF, as described (Matsui et al., 1992). The three homozygous
mutant ES cell lines and the EG cell line all showed equivalent
molecular characteristics and functional capacity before and after
transfection of the Dnmt cDNA, and they are collectively referred to
as "rescued ES cells" in the text.
Fibroblasts were prepared by maceration and trypsinization of
eviscerated, decapitated embryonic and post-natal carcasses and
grown in Dulbecco's modified Eagle's medium supplemented with
10% fetal calf serum, 0.1 mM nonessential amino acids (GIBCO), 0.1
mM f3-mercaptoethanol, and antibiotics. SV40 virus infection was as
described (Jat et al., 1986). To enrich for fibroblasts derived from
the rescued ES cells, puromycin (Sigma) selection (2 4gg/ml) was
applied after infection. Puromycin-selected populations were plated
at 0.5 - 1.0 cell / well density to produce subcloned lines. Subclones
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were chosen from those plates with less than 1 colony / 3 wells.
RNase protection experiments were performed on subcloned
fibroblasts prepared from a P7 (PO = day of birth) chimera made
between a rescued Dnmts/s EG cell line (described above) and a
BALB/c host. Methylation data was obtained from these cells and
fibroblasts prepared from two three month-old chimeras made with
a rescued Dnmts/s ES cell line.
CHIP (cDNA homologous insertion protocol)
All plasmids were prepared by alkali lysis from bacterial cultures
and purified by centrifugation in continuous CsCl-ethidium bromide
gradients (Sambrook et al., 1989). pMWT-PURO was made as follows.
The Dnmt cDNA was derived from pMG (gift of T. Bestor), which
comprises a 4934 bp Dnmt cDNA, starting at an EcoRI site 203 bp
upstream of the first ATG and terminating at a BglI site 226 bp
downstream of the stop codon TAG. This cDNA was inserted into
pPGK-CAS, to utilize the Pgk-1 polyadenylation tract, which
comprises the 500 bp PvuII-HindIII fragment at the 3' end of the
Pgk-1 cDNA (Adra et al., 1987). pPGK-CAS is described as the Pgk-1-
driven expression vector in van der Lugt et al. (1991). A 4.8-kb
Dnmt NaeI genomic fragment (Li et al., 1992) was cloned into a
unique Nael site in the open reading frame (ORF) of the Dnmt cDNA,
such that the Dnmt cDNA sequence removed upstream of the NaeI
site was restored in its genomic context. Finally, a puroR cassette
from pPgk-Puro was inserted downstream of the Dnmt cDNA. pPgk-
Puro consists of the 660-bp HindIII-Clal fragment of pBabePuro
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(Morgenstern and Land, 1990) cloned into pPGK-CAS through several
intermediate cloning steps.
This construct was designed to act as an insertion vector (Thomas
and Capecchi, 1987) using a unique HindIII site (Fig. lA), which lies
700 bp upstream of the NaeI site marking the genomic-cDNA
junction and 4.1 kb downstream of the 5' end of the genomic D nmt
fragment. The construct was linearized at this site and then
electroporated into ES cells. Upon homologous insertion at the D nmt
locus, the cDNA-genomic hybrid configuration of pMWT-PURO fused
the Dnmt promoter and any missing upstream exons to the Dnmt
cDNA. Dnmt mRNA transcripts were produced of the same size and
amount as the endogenous gene, and they were spliced appropriately
to allow production of the full-length protein. For electroporation,
approximately 107 ES cells were trypsinized and washed and
resuspended in 600 gl electroporation buffer, made as described
(Thomas and Capecchi, 1987), except with 137 mM NaC1 and 10 g g
linearized pMWT-PURO. The cell-DNA mixture was electroporated in
a BioRad Gene Pulser at 400 V and 25 gF. The cells were plated on
10-cm dishes pre-plated with y-irradiated, puromycin-resistant
embryonic fibroblasts prepared from pPgk-Puro transgenic mice
(kind gift of E. Simpson). Media containing 2 p g/ml puromycin
(Sigma) were changed every day, and isolated colonies picked 7-9
days after electroporation. DNA and RNA were analyzed by standard
procedures (see below).
Southern blot analysis.
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Genomic DNA was prepared from cell cultures and pup tails as
described (Laird et al., 1991). 10 ýgg of DNA was digested with 40
units of restriction endonuclease, except for HhaI and HpaII, which
were used at double this amount. Digested DNA was electrophoresed
in agarose gels, and blotted onto Zetabind nylon membranes (Cuno
Laboratory Products). Usual Southern blot procedures were used
(Sambrook et al., 1989), with hybridization buffer (Church and
Gilbert, 1984) and cX- 3 2 P dCTP-labeled probe (Feinberg and
Vogelstein, 1983) prepared as described. Blots were washed at 650 C
with 0.1X SSC / 0.1% SDS, and exposed to AR-X film (Kodak). The
following probes were used: HV is a 600-bp HindIII-EcoRV fragment
of genomic DNA which includes the first exon of Dnmt; pMO contains
a 5.5-kb MoMuLV cDNA fragment (Jihner et al., 1982); pMR150
contains a minor satellite centromeric repeat (Chapman et al., 1984;
gift of V. Chapman); pBSIISac contains a 3.8-kb genomic SacI
fragment from a region of the H19 gene starting 750 bp upstream of
the transcriptional start site, identical to the probe used in Tremblay
et al., (1995) (generously donated by M. Bartolomei); p1269 contains
a 720-bp EcoRI-Xbal genomic Igf2 fragment whose 5' end is
approximately 4.5 kb from the first exon, corresponding to probe 2
in Feil et al., (1994) (gracious gift of S. Tilghman); pPP4 contains a
1.1-kb BstBI-MluI genomic Igf2r fragment located within the
intronic region 2, identical to the probe used in St6ger et al., (1993)
(gift of D. Barlow); and pXistMcl contains a 1.5-kb Xist cDNA
fragment that includes the transcriptional start site, 1.5 kb of exon 1,
and the gamete-specific methylation sites as reported in Ariel et al.,
(1995) and Zuccotti and Monk (1995) (provided by H. Willard). A
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mitochondrial probe was used to assay for completeness of HhaI and
HpaII digestions, because the mitochondrial genome does not become
methylated. This was a gift of P. Laipis and comprises bp 4013 to
7720 of the published sequence from mouse L cells (Bibb et al.,
1981).
Northern blot analysis
RNA was prepared as described (Chomczynski and Sacchi, 1987),
from confluent ES cell cultures passaged without a fibroblast feeder
layer. Denatured RNA was electrophoresed in formaldehyde-
containing agarose gels and blotted onto Zetabind nylon membranes
(Cuno) as described (Sambrook et al., 1989). Hybridization, washing,
and exposure occurred as described above for DNA analysis. The
Dnmt cDNA from pMG was used for a probe, and an a-tubulin cDNA
probe (pILaT1) (Lemischka et al., 1981) was used to control for
loading amounts.
RNase protection assays
Assays were performed as described for H19, Igf2, and Igf2r (Li et
al., 1993), and for Xist (Beard et al., 1995).
Teratoma Formation and Generation of Germline Chimeras
Teratomas were produced by preplating 3 x 106 ES cells for 30' to
remove embryonic fibroblasts, resuspending them in 300 gl of PBS,
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and injecting them subcutaneously into the flanks of adult male
129/Sv mice. Wild-type J1, Dnmts/s, and rescued Dnmts/s EG and
Dnmtc/c ES cells were used. Tumors were excised at 3-4 weeks.
Chimeras were made as described (Li et al., 1992), except that 2-3 ES
or EG cells were injected into blastocysts. Male chimeras derived
from the two rescued Dnmts/s ES cell lines were mated to BALB/c
females, and progeny were analyzed with Southern blot and RNase
protection assays.
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FIGURE LEGENDS
Figure 1. CHIP (cDNA homologous insertion protocol) (A) Diagram
representing the Dnmt-targeting construct pMWT-PURO and its
method of integration into the Dnmt locus. pMWT-PURO is
represented schematically. A 4.8-kb Dnmt genomic sequence that is
shared between pMWT-PURO and the Dnmt locus is indicated by a
broken line and two downstream exons (dark boxes) drawn to scale.
This was fused to the remainder of the Dnmt cDNA (striped box) in
the second exon at a Nael (N) site, 20 bp upstream of the initial ATG.
A Pgk-1-derived polyadenylation sequence (Pgk-PolyA) was
inserted at the end of the cDNA, and the plasmid also contained a
puromycin-selectable marker (Pgk-Puro) and pGEM-llzf(+) bacterial
plasmid sequences (Ampr). The HindIII linearization site is
indicated (H). The Dnmt locus targeted with this construct is
represented by a broken line upstream of the same two exons
depicted in pMWT-PURO. The genomic probe (HV) for Southern blot
analysis and the Scal (S) digestion product expected from the locus
are also displayed. HindIll (H) and Nael (N) sites are as indicated
above. Within the vertical arrow is a close-up, drawn to scale, of the
crossover event in which pMWT-PURO was targeted to the Dnmt
locus. The plasmid was cut at the unique HindIII (H) site indicated,
and after electroporation the entire vector homologously inserted
into the endogenous gene, yielding the genomic structure shown
beneath. pMWT-PURO shares 4.1 and 0.7 kb of sequence identity
with the target locus 5' and 3', respectively, of the HindIII
linearization site. The bottom schematic illustrates the duplication of
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the 4.8-kb Dnmt genomic sequence expected upon integration, seen
with the exons (dark boxes) drawn to scale. It also displays the two
products expected from a Scal (S) digestion, using the HV probe. The
scale is interrupted by several breaks in the genomic sequence,
indicated by slashes through the line. The integrated pMWT-PURO
plasmid is indicated by a line. (B) Southern blot analysis of Dnmt-
targeted clones. Scal-digested genomic DNA displayed a single 17.5-
kb band from both untargeted Dnmt alleles in wild-type J1 (lane 1)
and homozygous Dnmt mutant (lane 2) cells. Homologous insertion of
a single copy of the pMWT-PURO plasmid at the Dnmt locus resulted
in production of 21- and 7.4-kb bands (lanes 3 , 4). The untargeted
allele is also visible at 17.5 kb. HindIII-digested ? DNA size
standards are indicated to the left. (C) Northern blot analysis of
Dnmt expression in ES cell lines stably transfected with pMWT-PURO.
Total RNA was prepared from the homologous integrants shown in
Fig. 1B (lanes 4, 5), and the Dnmt cDNA was used as a probe for the
Northern blot (upper figure). The following cells are shown for
comparison: wild-type J1 (lane 1), a heterozygous (lane 2), and
homozygous (lane 3) Dnmt mutant cell line. The lower figure
represents the same blot re-hybridized with an ox-tubulin cDNA, to
control for amount of RNA loaded. The positions of the 28S and 18S
ribosomal RNA species are indicated on the left.
Figure 2. Normal genomic DNA methylation levels are restored
upon expression of the Dnmt cDNA. Southern blot analysis of HpaII-
digested genomic DNA, probed with either of two repetitive
sequences: the Moloney Murine Leukemia Virus (MoMuLV) cDNA or
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a centromeric minor satellite repeat. Wild-type J1 (lane 1) and
homozygous Dnmt mutant ES cells (lane 2) are shown, followed by
the rescued mutant cells seen in Fig. 1 (lanes 3, 4). HindIll-digested
,k DNA size standards are indicated to the left of each blot.
Figure 3. Methylation of the imprinted genes H19 and Igf2r is not
restored in rescued ES cells and their differentiated derivatives, but
methylation of Xist and Igf2 is restored to normal. Southern blot
analysis of ES cells and fibroblast cultures derived from postnatal
chimeras made with rescued ES cells. (A, B, C, D) Genomic DNA was
isolated from undifferentiated (U) or differentiated (D) ES cells, cut
with SacI, PvuII, EcoRI-HindIII, or EcoRV ((A), (B), (C), and (D), lane
1, respectively), and probed with the gene sequence indicated
beneath each respective blot. All other lanes were treated similarly
but include the methylation-sensitive enzymes HhaI (A, D) or HpaII
(B, C). Wild-type J1 (+/+), homozygous Dnmt mutant (-/-), and two
independent rescued cell lines (-/- + cDNA) are shown. In lanes 10-
12 of (A) and (C), and lanes 6-8 of (B), SV40 virus-immortalized
fibroblast cultures were examined. Fibroblasts were derived from an
embryonic day 16.5 wild-type embryo (lane 10 of (A) and (C) and
lane 6 of (B)) and were compared with puromycin-resistant
fibroblasts derived from two postnatal chimeras (lanes 11, 12 of (A)
and (C) and 7, 8 of (B)). The puromycin-resistant cells were shown to
be derived exclusively from the injected rescued ES cells (data not
shown). A map of the examined area is shown underneath each blot,
with flanking Scal (S), PvuII (P), EcoRI (E), HindIII (H), and EcoR V
(V) sites indicated. The probes used and the genomic regions
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examined are described in Results and Materials and Methods. HhaI
(A, D) and HpaII (B, C) sites are represented by small vertical lines,
while transcriptional start sites are shown in (A) and (D) by an
arrow. HindIII-digested k DNA size standards are indicated to the
left of each blot.
Figure 4. Normal expression of imprinted genes is not restored in
rescued ES cells. (A, B, D, E) Total RNA isolated from undifferentiated
(U) and in vitro differentiated (D) ES cells was analyzed by RNase
protection using antisense RNA probes for H19 (A), Igf2r (B), Igf2
(D), and Xist (E). Antisense RNA probes for cytoplasmic actin (A, B)
or y actin (D, E) were used as loading controls. Wild-type J1 (+/+),
homozygous Dnmt mutant (-/-), and rescued ES cells (-/- + cDNA) are
shown. (C) Igf2r RNase protection assay performed upon subcloned
lines of immortalized fibroblasts prepared from a postnatal day 7
chimera made between rescued EG cells and a wild-type BALB/c
host. Lanes 1,2 show two wild-type BALB/c lines, while lanes 3-6
show four puromycin-resistant lines derived from the injected
rescued EG cells. Antisense RNA probes for Igf2r and y actin (as a
loading control) were used.
Figure 5. Normal methylation and expression patterns of imprinted
genes are restored after passage through the germline. Southern blot
and RNase protection analysis of germline embryos and pups
produced by a chimera made from rescued ES cells. (A, B, C) RNase
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protection analysis performed upon whole RNA from embryos, using
probes indicated in Fig. 4. A male chimera was mated to BALB/c
females, and embryos analyzed at embryonic day 19.0. Black-eyed
embryos (R), derived by germline transmission of the rescued ES
cells, were compared to albino wild-type littermates (+/+). (D, E, F)
Southern blot analysis of genomic DNA from postnatal mice. DNA
prepared from tails of three-week old mice was digested with
methylation-sensitive enzymes and probed with H19, Igf2, or Igf2r
sequences, as described in Fig. 3A, 3C, and 3B, respectively. A wild-
type Fl (BALB/c x 129/Sv) mouse (lane 1) was compared to three
germline pups derived from a cross between a chimera generated
with rescued ES cells and a BALB/c female (lanes 2-4). HindIII-
digested X DNA size standards are indicated to the left of each blot.
Figure 6. (A) Developmental changes in methylation of bulk DNA
and imprinted genes. Bulk DNA and non-imprinted genes undergo
consecutive waves of demethylation and de novo methylation in
early development before the adult somatic patterns are established
(Razin and Shemer, 1995). Xist is depicted as non-imprinted as its
expression is only imprinted in extraembryonic tissues. The
monoallelic methylation patterns of the imprinted genes H19 and
Igf2r are established in the male and female gametes, respectively,
and are not altered throughout development. (B) Methylation is
almost completely erased for all examined DNA sequences in Dnmt
mutant ES cells and embryos. Expression of the Dnmt cDNA in
mutant ES cells restores the methylation of bulk DNA and single-copy
genes such as Xist, but does not restore methylation to imprinted
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genes such as H19 and Igf2r. Methylation of these genes is restored
only after transmission through the germline of male and female
chimeras, respectively, implying the presence of gamete-specific DNA
methylation processes for imprinted genes. Degree of shading in
boxes indicates extent of DNA methylation. Maternally- and
paternally-derived alleles are both displayed for H19 and Igf2r.
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